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Abstract 
In mammals, females have two X-chromosomes, while males have one X- and one Y-
chromosome. In order to equalise X-linked gene expression between the sexes, one of the 
two X-chromosomes is transcriptionally inactivated in female mammals, a process called X-
chromosome inactivation (XCI). This process starts very early in female mouse embryonic 
development, with imprinted inactivation of the paternally inherited X-chromosome in all cells 
of the embryo. The silent X-chromosome is then transiently reactivated exclusively in the 
naïve epiblast, which contains the cells that will generate the entire embryo proper. Shortly 
after implantation, one of the two X-chromosomes is randomly inactivated in epiblast cells. 
The transient stage between imprinted and random inactivation is characterised by the 
presence of two active X-chromosomes. In fact, the presence of two active X-chromosomes 
in female cells is one of the epigenetic signatures of naïve pluripotency, a feature of the late 
pre-implantation epiblast and of its in vitro counterpart, embryonic stem cells. As female 
naïve pluripotent stem cells (nPSCs) differentiate, the master regulator of XCI, Xist, is 
upregulated monoallelically and coats the inactivating X-chromosome. Even though there is 
a strong correlation between differentiation and XCI, it is not known whether prevention of 
XCI is mediated by gene networks that also preserve the naïve pluripotent state. Thus, the 
main aim of this work was to explore the link between naïve pluripotency and XCI. 
Here, I show that expression of Xist is repressed by a robust naïve transcription factor 
network, which can be achieved through the use of optimal nPSC culture conditions. When 
perturbation of the naïve network was induced through ablation of key components of the 
network, Xist expression was highly upregulated not only in female but also in male cells. 
This prompted me to revisit the kinetics of Xist expression during nPSC differentiation. 
Surprisingly, I found that Xist is transiently and rapidly upregulated in early 
differentiating male cells. The data presented here show that Xist upregulation is gender-
independent and linked to the downregulation of naïve pluripotency factors. Moreover, I 
demonstrate that nPSCs accumulate Xist on the single male X-chromosome and on both 
female X-chromosomes as they become NANOG-negative at the onset of differentiation. 
This is accompanied by appearance of a repressive chromatin signature and partial X-linked 
transcriptional silencing. 
Xist expression was also assessed in male and female mouse embryos at different 
stages. I observed that Xist is not expressed in pre-implantation naïve epiblast cells in either 
sex, and that it is transiently expressed in males from the single X-chromosome and in 
females from both X-chromosomes at the onset of naïve epiblast differentiation. 
viii 
In conclusion, these findings demonstrate that XCI initiation is gender-independent, 
and that it is triggered by destabilization of naïve identity. Importantly, this suggests that 
gender-specific mechanisms follow, rather than precede, XCI initiation. This change in the 
paradigm of XCI opens up new avenues to investigate how this process is regulated. 
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Resumo 
As fêmeas de mamíferos possuem dois cromossomas X, enquanto que os machos possuem 
um cromossoma X e um Y. De forma a equalizar a expressão dos genes localizados no 
cromossoma X entre os dois sexos, um dos dois cromossomas X é inactivado 
transcricionalmente em mamíferos fêmea através de um processo chamado inactivação do 
cromossoma X (XCI). Este processo começa durante as etapas iniciais do desenvolvimento 
embrionário da fêmea de murganho com a inactivação “imprinting” do cromossoma X de 
origem paterna em todas as células do embrião. O cromossoma X inactivo é depois 
reactivado de forma transiente exclusivamente no epiblasto “naïve” que contém as células 
que darão origem ao embrião propriamente dito. Logo após a implantação, um dos dois 
cromossomas X é inactivado aleatoriamente nas células do epiblasto. O estado transiente 
entre a inactivação “imprinting” e a aleatória é caracterizado pela presença de dois 
cromossomas X activos. De facto, a presença de dois cromossomas X activos em células 
fêmea é uma das “assinaturas” epigenéticas da pluripotência “naïve” que, por sua vez, pode 
ser encontrada no epiblasto pré-implantação tardio e no seu homólogo in vitro, as células 
estaminais embrionárias. Durante a diferenciação das células estaminais pluripotentes naïve 
(nPSCs) fêmea, o principal regulador da XCI, Xist, aumenta a expressão de um dos seus 
alelos e reveste o futuro cromossoma X inactivo. Embora exista uma forte correlação entre a 
diferenciação e a XCI, não se sabe se a XCI é regulada pelos mesmos genes que regulam a 
pluripotência naïve. Assim, o principal objectivo deste trabalho foi explorar a relação entre a 
pluripotência naïve e a XCI. 
Aqui, demonstro que a expressão do Xist é reprimida por uma rede robusta de 
factores de transcrição associados ao estado “naïve”, que pode ser obtida através do uso de 
condições de cultura ideais para as nPSCs. Quando esta rede de factores de transcrição foi 
perturbada através da remoção dos seus componentes, a expressão do Xist aumentou não 
só em células fêmea, mas também em células macho. Estes resultados levaram-me a 
revisitar a cinética da expressão do Xist durante a diferenciação de nPSC. 
Surpreendentemente, descobri que a expressão do Xist aumenta de forma transiente 
e rápida no início da diferenciação das células macho. Os dados aqui apresentados 
demonstram que este aumento na expressão do Xist é independente do género e que está 
ligado à diminuição da expressão dos factores de transcrição “naïve”. Também demonstrei 
que as nPSCs acumulam Xist no único cromossoma X dos machos e em ambos os 
cromossomas X das fêmeas, assim que as células se tornam negativas para a proteína 
NANOG no início da diferenciação. Isto é acompanhado pelo aparecimento de uma 
x 
“assinatura” repressiva da cromatina e pelo silenciamento parcial dos genes localizados no 
cromossoma X. 
A expressão do Xist foi também avaliada em embriões de murganho macho e fêmea 
em diferentes estadios do desenvolvimento. Constatei que o Xist não é expresso nas células 
do epiblasto “naïve” pré-implantação em nenhum dos sexos, e que é posteriormente 
expresso de forma transiente em machos no seu único cromossoma X e em fêmeas em 
ambos os cromossomas X no início da diferenciação do epiblasto “naïve”.  
Em conclusão, estes resultados demonstram que a iniciação da XCI é independente 
do género e que é desencadeada pela desestabilização da identidade “naïve”. Isto sugere 
que, ao contrário do que se pensava, mecanismos específicos do género ocorrem após a 
iniciação da XCI. Esta mudança no paradigma da XCI abre novos caminhos na investigação 
da regulação deste processo. 
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 Chapter 1 
Introduction 
 
 X-chromosome inactivation 1.1
In mammals, females have two X-chromosomes and males an X- and a Y-chromosome. 
Whereas the X-chromosome is large and gene rich, the Y-chromosome has been subject to 
degradation during mammalian evolution due to its lack of recombination during meiosis 
(Graves, 2006). As a consequence, the Y-chromosome carries very few functional genes 
which results in an unequal dosage between males and females for the X-linked genes with 
no Y partner.  In order to equalise X-linked gene expression between the sexes, one of the 
two X-chromosomes is transcriptionally inactivated in female mammals early in development. 
This process is called X-chromosome inactivation (XCI) and was observed for the first time 
by Mary Lyon (Lyon, 1961). Dosage compensation of sex chromosomes is crucial for 
mammalian development to progress properly, as shown by the fact that ablation of the 
master regulator of XCI, Xist, leads to female-specific lethality early in mouse embryonic 
development (Marahrens et al., 1997; Penny et al., 1996). 
The mouse is the most well characterised XCI model system. During female mouse 
embryonic development, XCI occurs in two waves (Figure 1.1). A first wave of XCI takes 
place between 4- to 8- cell stage (Okamoto et al., 2004). This leads to inactivation of the 
paternally transmitted X-chromosome in all cells of the early embryo in a process known as 
imprinted XCI (Takagi and Sasaki, 1975; West et al., 1977). At embryonic day (E) 4.5, the 
paternal X-chromosome is transiently reactivated in cells of the naïve pluripotent epiblast 
(Mak et al., 2004; Okamoto et al., 2004; Silva et al., 2009; Williams et al., 2011), whereas 
imprinted XCI persists in the extraembryonic tissues (Harper et al., 1982). Around 24 hours 
later, shortly after implantation, there is a second wave of XCI which results in random 
inactivation of either the maternal or the paternal X-chromosome in epiblast cells (Okamoto 
et al., 2005). Once random XCI is completed, the inactive X-chromosome (Xi) is clonally 
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propagated throughout cell division, meaning that the same X-chromosome remains 
inactivated in all daughter cells (Plath et al., 2002). 
 
Figure 1.1: XCI during female mouse embryonic development.  
Imprinted inactivation of paternal X-chromosome takes place between 4- to 8-cell stage in all 
cells of female the embryo. The paternal X-chromosome is then reactivated at E4.5 in cells of 
the pre-implantation epiblast (yellow), whereas extraembryonic tissues, including the 
primitive endoderm (blue) and the trophectoderm (grey), maintain imprinted inactivation. At 
E5.5, the post-implantation epiblast undergoes random XCI.  
 
The process of random XCI gives rise to cellular mosaicism in females. Cellular mosaicism 
confers females with a significant biological advantage by ameliorating the deleterious effects 
of X-linked mutations. As a consequence, only males are affected by many of the disorders 
caused by X-linked mutations, such as Wiskott-Aldrich syndrome and Duchenne's muscular 
dystrophy (Migeon, 2006). Conversely, some X-linked diseases are only observed in 
females, since in males they are lethal either in utero or in early childhood (e.g., incontinentia 
pigmenti and Rett syndrome) (Migeon, 2006). 
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 Random XCI in mice 1.1.1 
According to the prevailing paradigm, random XCI can be divided into five phases in the 
following order: counting, choice, initiation, establishment, and maintenance (Avner and 
Heard, 2001; Boumil and Lee, 2001; Lyon, 1999). With the exception of maintenance, these 
phases appear to be controlled by the X-chromosome inactivation centre (Xic), a ~500 kb 
region located on the X-chromosome that harbours Xist (Heard et al., 1994; Lee et al., 1996; 
Rastan, 1983; Rastan and Robertson, 1985). The Xic was first proposed as the master 
regulatory locus for XCI not long after XCI itself was discovered (Russell, 1963).  
During the counting step, a cell determines its X/autosome ratio in order to maintain 
only one active X-chromosome (Xa) per diploid autosome set. This process was described 
for the first time by Lyon and Grumbach based on humans with abnormal numbers of X-
chromosomes (Grumbach et al., 1963; Lyon, 1962). 
During choice, all but one X-chromosome is selected to become inactivated. In the 
case of diploid female mouse cells, one of the two X-chromosomes is chosen for inactivation. 
It is hypothesised that the future Xi and Xa are chosen during the process of X-pairing, in 
which the Xic of both X-chromosomes transiently move into close spatial proximity (Augui et 
al., 2007; Bacher et al., 2006; Xu et al., 2006). However, a different study reported that 
heterozygous deletion of the region identified as required for pairing does not affect XCI in 
mouse embryonic stem cells (ESCs) suggesting that pairing is not required for XCI to occur 
(Barakat et al., 2014).  
Initiation of XCI coincides with the upregulation of Xist from the future Xi (Brown et al., 
1991). It has been proposed that XCI activators, also contained within the Xic, act in a dose-
dependent manner to activate Xist (Jonkers et al., 2009; Monkhorst et al., 2009). These 
activators are predicted to be counteracted by autosomally-encoded XCI inhibitors that are 
equally expressed between male and female cells. In contrast, as XCI activators are X-
encoded, they will be present in a double dose in the epiblast of the female embryo, or in 
female ESCs, relative to males. This will ensure that only female cells can overcome the 
threshold for XCI to occur. Moreover, silencing of the X-encoded activators will decrease the 
probability of the second X-chromosome to initiate XCI ensuring that one of the X-
chromosomes remains active (Chureau et al., 2011; Tian et al., 2010). The role of Xist and 
its activators and inhibitors will be further discussed in sections 1.1.3 and 1.1.4. 
In the establishment phase, Xist spreads and coats the entire future Xi in cis in order 
to silence it. Xist spreading is accompanied by depletion of basic transcriptional machinery 
and of active chromatin marks, such as histone H3 lysine 4 dimethylation and trimethylation 
(H3K4me2/me3) and histone H3 and histone H4 acetylation (H3/H4Ac) (Goto et al., 2002; 
Heard et al., 2001; O'Neill et al., 2008). After the loss of euchromatin marks, Polycomb 
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complex 1 and 2 (PRC1 and PRC2) are recruited (de Napoles et al., 2004; Plath et al., 2004; 
Schoeftner et al., 2006; Zhao et al., 2008) and catalyse the accumulation of the repressive 
chromatin marks histone H3 lysine 27 trimethylation (H3K27me3) (Plath et al., 2003; Silva et 
al., 2003) and monoubiquitylation of lysine 119 of histone H2A (H2A119ub) (de Napoles et 
al., 2004). These epigenetic changes are followed by incorporation of the histone variant 
macroH2A (Costanzi et al., 2000; Mermoud et al., 1999; Mietton et al., 2009), DNA 
methylation at CpG islands of X-linked genes (Grant et al., 1992; Kaslow and Migeon, 1987) 
and, finally, accumulation of histone H3 lysine 9 dimethylation (H3K9me2) (Heard et al., 
2001; Rougeulle et al., 2004). All these features of the Xi are important to ensure that the 
silenced state of the X-chromosome is permanently locked in. 
Once XCI is complete, the Xi is maintained in an inactive state and clonally 
propagated throughout cell divisions. As previously mentioned, the initiation of XCI relies on 
Xist expression, but once silencing is established, maintenance of the inactive state appears 
to be independent of further Xic and Xist activity (Brown and Willard, 1994; Csankovszki et 
al., 1999). 
 
 Xist, the master regulator of XCI 1.1.2 
The Xist (X-inactive specific transcript) gene was first identified in the early 1990s as a 
candidate for the master regulatory switch locus required in cis for XCI to occur (Borsani et 
al., 1991; Brockdorff et al., 1991; Brown et al., 1991). Xist is located in the Xic (Figure 1.2) 
and encodes a long non-coding RNA that is around 17 kb in length and that is retained in the 
nucleus (Borsani et al., 1991; Brockdorff et al., 1992; Brown et al., 1992). There are two 
major Xist isoforms which are produced through use of different termination signals (Ma and 
Strauss, 2005). 
Figure 1.2: The mouse Xic. 
Schematic overview of the mouse Xic. The Xic encompasses not only Xist but also its 
regulatory elements. Adapted from Galupa and Heard, 2015. 
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It has been reported that Xist is expressed at low levels in undifferentiated female and 
male ESCs (Panning et al., 1997; Sheardown et al., 1997). In the female, Xist is 
monoallelically upregulated at the onset of XCI and coats the future Xi in cis triggering a 
cascade of chromosome-wide events that result in transcriptional silencing and 
heterochromatinization of that X-chromosome (Escamilla-Del-Arenal et al., 2011; Splinter et 
al., 2011).  
Several studies demonstrated that Xist is both necessary and sufficient for initiation of 
XCI. The requirement of Xist for XCI has been demonstrated by experiments on female 
ESCs harbouring a heterozygous Xist deletion, which exhibit skewed inactivation towards the 
wild-type X-chromosome (Penny et al., 1996). On the other hand, ectopic expression of Xist 
from multicopy transgenes causes autosomes to display features of XCI, showing that Xist is 
sufficient for initiation of chromosome inactivation (Herzing et al., 1997; Lee and Jaenisch, 
1997). Furthermore, Wutz and Jaenisch demonstrated that, during the early stages of 
differentiation, X-linked gene silencing is dependent on continued Xist expression and is 
reversible. However, by day 3 of ESC differentiation, XCI becomes permanent and 
independent of Xist (Wutz and Jaenisch, 2000).  
Xist RNA is poorly conserved between placental mammals, except for a series of 
unique tandem repeats termed A-F, which vary in size and number among species (Brown, 
1991; Hendrich et al., 1993; Nesterova et al., 2001; Yen et al., 2007). The most conserved 
sequence in the Xist gene is an A-repeat region that is close to the 5’ end. Molecular 
genetics studies have shown that this is required for Xist-mediated silencing, but not for 
coating of the X-chromosome (Wutz et al., 2002). Other regions have been shown to be 
critical to Xist localization to the X-chromosome (Beletskii et al., 2001; Sarma et al., 2010) 
and to the ability of Xist to recruit chromatin-modifying factors such as PRC2 (da Rocha et 
al., 2014; Kohlmaier et al., 2004; Zhao et al., 2008).  
 
 Cis-regulation of XCI 1.1.3 
The Xic encompasses not only Xist but also its known and putative cis-regulatory elements 
(Figure 1.2). Tsix is one of these regulatory factors and is transcribed antisense to Xist (Lee 
et al., 1999). It has been proposed that Tsix transcription is required to repress Xist on the 
future Xa (Lee, 2000; Lee and Lu, 1999; Luikenhuis et al., 2001; Navarro et al., 2005; Sado 
et al., 2005; Sado et al., 2001; Stavropoulos et al., 2001). Tsix also plays a role in 
determining which X-chromosome will be silenced as shown by its heterozygous deletion 
leading to skewed Xist expression and non-random inactivation of the mutated chromosome 
(Lee and Lu, 1999). Moreover, it has been shown that Tsix is one of the elements involved in 
the process of X-pairing (Masui et al., 2011).  
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The non-protein-coding gene Ftx, which is located in close proximity to Xist, has been 
reported to participate in activation of Xist (Chureau et al., 2011). Ftx deletion in male ESCs 
results in decreased expression of Xist as well as other loci across Xic (Chureau et al., 
2011). However, deleting Ftx in female pre-implantation embryos had no impact on Xist 
expression (Soma et al., 2014).  
The Jpx locus also produces a non-coding RNA that has been described to positively 
regulate Xist (Tian et al., 2010), even though there is no agreement on whether it acts in cis 
or in trans. A heterozygous deletion of Jpx in female ESCs has been reported to decrease 
Xist upregulation in both alleles, which could be rescued by an autosomal transgene, 
suggesting Jpx to act in trans (Tian et al., 2010). The trans activity of Jpx has been proposed 
to occur by dose-dependent eviction of CTCF at the Xist promoter (Sun et al., 2013). 
However, in a more recent study, a large deletion encompassing Jpx locus in female ESCs 
affected XCI and this could not be rescued by random integration of Jpx transgene, 
indicating only a cis mechanism of action (Barakat et al., 2014). 
The X-pairing region (Xpr), previously implicated in Xic pairing, was also proposed to 
induce Xist expression in trans (Augui et al., 2007). However, Barakat and colleagues 
reported that Xpr does not seem to act in trans, but instead enhances Xist expression 
through a cis-mediated mechanism (Barakat et al., 2014). 
 
 Trans-regulation of XCI 1.1.4 
Rnf12, which is located within the Xic (Figure 1.2), has been proposed to upregulate Xist in 
trans in a dose-dependent manner (Jonkers et al., 2009). It encodes an E3 ubiquitin ligase 
that promotes the degradation of the Xist repressor REX1. In male ESCs, extra copies of 
Rnf12 lead to activation of Xist expression (Gontan et al., 2012). Homozygous knockout of 
Rnf12 resulted in lack of XCI in differentiating female ESCs (Gontan et al., 2012). In contrast, 
Shin and colleagues reported that, although Rnf12 seems to be required for imprinted XCI in 
vivo, its knockout did not impact on random XCI (Shin et al., 2010; Shin et al., 2014). This 
discrepancy might be explained by the fact that RNF12 protein was not entirely abrogated 
and the sequences deleted were not the same in both studies.  
XCI occurs during a specific developmental time window and has been linked to the 
pluripotency network. Some of the pluripotency-associated factors have been proposed to 
repress XCI either by stimulation of Tsix or by suppression of Xist expression (Galupa and 
Heard, 2015). The regulation of XCI by pluripotency factors will be further discussed in 
section 1.3. 
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 Pluripotency in the embryo and in culture 1.2
The dynamics of XCI are tightly coupled with the progression of embryonic development. 
Remarkably, the link between XCI and differentiation was first proposed in the late 1970s 
using mouse embryos as a model system (Monk and Harper, 1979). A few years later, it 
became possible to culture mouse ESCs (Evans and Kaufman, 1981; Martin, 1981), which, if 
female, retain the XaXa status of the pre-implantation epiblast cells from which they are 
derived and undergo random XCI upon differentiation (Rastan and Robertson, 1985). Since 
then, mouse ESCs have become the prevailing in vitro model system to study the process of 
random XCI. Furthermore, there has been a growing interest in how XCI and pluripotency 
are related. In the study conducted here, I attempted to further explore the link between XCI 
and naïve pluripotency and, for that purpose, used ESCs as a model system. Therefore, I will 
now introduce relevant aspects of pluripotency that will be important for this dissertation. 
Pluripotency is the potential of a single cell to give rise to all somatic lineages that 
constitute an organism, comprising mesoderm, endoderm and ectoderm derivatives, as well 
as the germ cells. Cells within the epiblast of the early mammalian embryo are pluripotent 
and represent the founding cell population of the embryo proper (Arnold and Robertson, 
2009). In the mouse embryo, pluripotent cells emerge in the inner cell mass (ICM) at E3.5 
and persist until the onset of somitogenesis at E8.5 (Morgani et al., 2017; Smith, 2017). 
During this period, the pluripotent population undergoes dynamic transcriptional and 
epigenetic changes, including changes in the X-chromosome status. 
The study of pluripotency began with the observation that mice of the 129 strain 
spontaneously developed teratocarcinoma, which is a malignant tumour composed of 
differentiated derivatives of all three germ layers and an undifferentiated proliferative 
component (Stevens and Little, 1954). Pluripotent stem cells isolated from these tumours, 
known as embryonal carcinoma cells (ECCs), could be clonally expanded in culture, while 
retaining their pluripotency, but their tumourigenicity and karyotypic abnormality was 
problematic (Kahan and Ephrussi, 1970; Martin and Evans, 1975). ECC-conditioned medium 
subsequently allowed derivation of the so-called ESCs from pre-implantation mouse embryos 
(Evans and Kaufman, 1981; Martin, 1981). ESCs exhibited a normal karyotype and could be 
incorporated into chimeric mice without forming tumours (Bradley et al., 1984). Post-
implantation epiblast cells, however, cannot be maintained in any of the culture systems 
used for ESC propagation. Instead, an alternative type of pluripotent stem cell line, termed 
epiblast stem cells (EpiSCs), can be derived from post-implantation embryos using different 
growth conditions (Brons et al., 2007; Tesar et al., 2007). EpiSCs are very different from 
ESCs transcriptionally, epigenetically, metabolically and functionally (Morgani et al., 2017). 
The terminology “naïve” and “primed” was introduced to describe the early and late phases, 
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respectively, of pluripotency in utero, and the corresponding ESC and EpiSC states in vitro 
(Nichols and Smith, 2009).  
 
 Naïve pluripotency 1.2.1 
1.2.1.1 Derivation and culture of embryonic stem cells 
Mouse ESCs can be isolated from and resemble the naïve epiblast of E3.5-4.5 pre-
implantation embryos (Boroviak et al., 2014; Brook and Gardner, 1997; Evans and Kaufman, 
1981; Martin, 1981). ESCs were first derived by co-culture with a feeder layer of mitotically 
inactivated fibroblasts in poorly defined medium containing fetal calf serum (Evans and 
Kaufman, 1981; Martin, 1981). However, the efficiency of these culture conditions was highly 
dependent on the genetic background of mice (Brook and Gardner, 1997). In fact, almost all 
ESC lines efficiently derived using serum and feeders are from the 129 strain of mice. The 
first step towards a defined culture system was the identification of leukaemia inhibitory 
factor (LIF) as the cytokine produced by feeders to support ESC self-renewal (Smith et al., 
1988; Williams et al., 1988). By adding LIF to the culture medium (Serum/LIF, SL), ESCs 
could be propagated on gelatin-coated dishes without feeders, making ESC culture simpler 
while maintaining the capacity to contribute to chimeras.  
LIF signals through a bipartite receptor complex composed of LIF receptor α (LIFR) 
and gp130 to activate Janus-associated kinases (JAKs). In response to JAK activation, 
STAT3 is recruited to the LIF receptor complex and activated through phosphorylation by 
JAK. STAT3 activation was demonstrated to be critical for LIF-mediated ESC self-renewal 
(Boeuf et al., 1997; Matsuda et al., 1999; Niwa et al., 1998). The main downstream targets of 
STAT3 activation in ESCs are the pluripotency-related genes Klf4, Klf5, Tfcp2l1 and Nanog 
(Bourillot et al., 2009; Martello et al., 2013; Niwa et al., 2009; Stuart et al., 2014; Ye et al., 
2013). However, ESCs cultured in SL are very heterogeneous, not only morphologically but 
also in terms of expression of pluripotency genes, and exhibit some degree of spontaneous 
differentiation (Chambers et al., 2007; Hayashi et al., 2008; Niwa et al., 2009; Toyooka et al., 
2008; van den Berg et al., 2008).  Therefore, there was a need to develop alternative culture 
conditions that could allow these limitations to be overcome. Serum-free culture of ESCs was 
made possible by combining BMP4 and LIF (Ying et al., 2003). Even though this finding 
provided a defined culture condition, neither maintenance of homogeneous cultures nor 
derivation of ESCs from different mouse strains were achieved.  
Differentiation of ESCs involves activation of MAPK/ERK pathway in an autocrine 
manner via FGF4 (Kunath et al., 2007; Stavridis et al., 2007). Although BMP and LIF 
suppress differentiation, they do not block the activation of MAPK/ERK pathway. Therefore, 
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ways of suppressing this signalling pathway were investigated. Propagation of ESCs without 
BMP or LIF was achieved by combining selective inhibitors of both MEK/ERK and GSK3 
pathways, PD0325901 and CH99021 respectively (Ying et al., 2008). These two small-
molecule inhibitors are now widely used to culture ESCs in defined serum-free medium 
(N2B27) and this culture system is known as 2i medium. Inhibition of MEK/ERK signalling 
pathway blocks ESC differentiation into all three lineages (Kunath et al., 2007), whereas 
GSK3 inhibition promotes self-renewal, mainly through activation of canonical Wnt/β-catenin 
signalling, which leads to the inhibition of the transcriptional repressor TFC3, therefore 
abrogating its inhibitory effect on the pluripotency network (Shy et al., 2013; Wray et al., 
2011; Yi et al., 2011).  
2i together with LIF (2i/LIF, 2iL) yields an optimal culture of naïve ESCs. ESCs in 2iL 
form compact, dome-shaped colonies, morphologically distinct from SL ESCs. Importantly, 
2iL medium eliminates the heterogeneity and spontaneous differentiation characteristic of 
ESCs maintained in SL and maximises the efficiency of ESC clonal expansion (Wray et al., 
2011; Wray et al., 2010). Unlike in pairwise combinations, provision of all three 2iL 
components fully suppresses lineage marker expression and differentiation biases (Hackett 
et al., 2017). Moreover, 2iL culture conditions allowed the derivation of stable ESCs from 
mice with different genetic backgrounds (Kiyonari et al., 2010; Nichols et al., 2009) and also 
from the rat (Buehr et al., 2008; Li et al., 2008) demonstrating that ESC derivation is not an 
artefact of the 129 mouse strain. Finally, the efficiency of molecular reprogramming of mouse 
somatic cells into induced pluripotent stem cells (iPSCs) (Takahashi and Yamanaka, 2006) is 
improved by 2iL (Silva et al., 2008). 
 
1.2.1.2 Transcriptional and epigenetic profiles 
The core circuitry of the pluripotency gene regulatory network consists of three transcription 
factors: OCT4, SOX2 and NANOG (Li and Izpisua Belmonte, 2018; Ng and Surani, 2011; 
Young, 2011). OCT4, also known as POU5F1, belongs to the Pit-Oct-Unc (POU) family of 
transcription factors. Oct4 expression starts very early during mouse embryonic development 
and, at E4.5, it is highly expressed in the naïve epiblast and is also detected in the primitive 
endoderm layer (Nichols et al., 1998; Rosner et al., 1990; Yeom et al., 1996). In vitro, Oct4 is 
essential for the maintenance of pluripotency in a dose-dependent manner. Deletion of Oct4 
leads to trophectoderm differentiation, whereas its overexpression induces differentiation into 
a mixture of lineages (Niwa et al., 2000). Both in ESCs and in the E4.5 embryo, Oct4 
expression is regulated by its distal enhancer element (Yeom et al., 1996). Furthermore, 
OCT4 is widely used as one of the components of the transcription factor cocktails used to 
generate iPSCs (Li and Izpisua Belmonte, 2016; Takahashi and Yamanaka, 2016). Sox2 is a 
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SRY-related HMG box transcription factor. SOX2 and OCT4 form heterodimers and act 
synergistically in the regulation of several downstream targets, including Sox2 and Oct4 
themselves as well as Nanog (Chew et al., 2005; Kuroda et al., 2005; Nakatake et al., 2006; 
Nishimoto et al., 1999; Rodda et al., 2005; Tokuzawa et al., 2003; Tomioka et al., 2002; 
Yuan et al., 1995). At E4.5, SOX2 expression is confined to the naïve epiblast (Avilion et al., 
2003). Similarly to Oct4, Sox2 is essential for pluripotency maintenance and its abrogation in 
ESCs induces differentiation towards trophectoderm lineage (Masui et al., 2007). NANOG is 
a homeodomain-containing transcription factor. In vivo, its expression is heterogeneous in 
the ICM at E3.5, but becomes homogeneous and exclusive to the epiblast at E4.25 
(Chambers et al., 2003; Silva et al., 2009). Nanog is required for the formation of the naïve 
pluripotent epiblast (Mitsui et al., 2003; Silva et al., 2009), even though Nanog-null ESCs can 
be generated in vitro (Chambers et al., 2007). 
In addition to the core pluripotency factors, ESCs express a set of transcriptions 
factors that are characteristic of the pre-implantation epiblast but are downregulated in the 
primed epiblast. Esrrb, Tfcp2l1, Klf2, Klf4, Gbx2 and Tbx3 are among those factors and have 
all been demonstrated to play a role in functionally maintaining ESC self-renewal (Ivanova et 
al., 2006; Martello et al., 2013; Martello et al., 2012; Niwa et al., 2009; Tai and Ying, 2013; 
Ye et al., 2013). Furthermore, they are all part of a highly interconnected network (Dunn et 
al., 2014; Martello and Smith, 2014). 
Notably, ESCs cultured in SL or 2i display distinct transcriptome profiles. SL ESCs 
exhibit greater heterogeneity in expression of pluripotency factors and increased expression 
levels of lineage markers (Marks et al., 2012). Moreover, ESCs in 2iL more closely resemble 
the transcriptome profile of the pre-implantation epiblast from which they are derived 
(Boroviak et al., 2014). 
The nPSC state is characterised by an open chromatin structure that allows 
transcriptional programmes to switch rapidly during lineage allocation (Meshorer and Misteli, 
2006). This means that ESC chromatin is less condensed (Efroni et al., 2008) and exhibits 
fewer heterochromatin foci (Park et al., 2004) than somatic cells. Importantly, the mouse pre-
implantation epiblast shares the same open chromatin conformation as ESCs (Ahmed et al., 
2010). Global DNA hypomethylation is also an epigenetic feature of the naïve epiblast (Smith 
et al., 2012). Although DNA methylation in SL ESCs is comparable to somatic cells, ESCs 
maintained in 2iL exhibit DNA methylation levels similar to the pre-implantation epiblast (Ficz 
et al., 2013; Habibi et al., 2013; Leitch et al., 2013).  
As previously mentioned, the presence of two Xa in females is another epigenetic 
hallmark shared between ESCs and the naïve pluripotent epiblast (Mak et al., 2004; 
Okamoto et al., 2004; Silva et al., 2009; Williams et al., 2011). In fact, this characteristic is 
used as a measure of the true naïve pluripotent nature of ESCs. 
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 Primed pluripotency 1.2.2 
1.2.2.1 Derivation and culture of epiblast stem cells 
EpiSCs can be derived from the post-implantation epiblast from E5.5 until E7.5 (Brons et al., 
2007; Osorno et al., 2012; Tesar et al., 2007) and are routinely maintained in N2B27 medium 
supplemented with FGF2 and Activin A (FA) (Brons et al., 2007; Tesar et al., 2007). Notably, 
the culture conditions applied to derive EpiSCs are essentially the same as those used for 
propagating human ESCs (Thomson et al., 1998). Even though human ESCs are derived 
from pre-implantation embryos, they share more features with mouse EpiSCs than mouse 
ESCs (Bates and Silva, 2017).  
EpiSCs are morphologically distinct from ESCs, presenting a flattened epithelial 
morphology. ESCs can be differentiated in vitro into cells resembling EpiSCs by prolonged 
culture in EpiSC culture conditions (Guo et al., 2009; Tosolini and Jouneau, 2016). 
Importantly, ESC-derived EpiSCs are transcriptionally similar to EpiSC lines derived from 
embryos (Hayashi et al., 2011). Conversely, embryo-derived EpiSCs can be reprogrammed 
to naïve pluripotency by transfection with just a single factor, such as Klf4, together with a 
switch to 2iL culture conditions (Guo et al., 2009). 
EpiSCs are heterogeneous within and among cell lines. This heterogeneity can be 
reduced to some extent through inhibition of WNT stimulation (Kim et al., 2013; Kurek et al., 
2015; Sugimoto et al., 2015; Sumi et al., 2013). XAV 939 is a tankyrase inhibitor that can be 
added to the EpiSC culture resulting in suppression of canonical WNT signalling pathway 
and consequent increased EpiSC homogeneity (Huang et al., 2009; Sumi et al., 2013).  
Contrary to ESCs, EpiSCs contribute poorly to chimeras when injected into E3.5 
embryos (Brons et al., 2007; Tesar et al., 2007). However, when introduced into post-
implantation embryos up to E8.5, they are able to integrate and contribute to development, 
which indicates functional equivalence between EpiSCs and post-implantation epiblast cells 
from the embryo (Huang et al., 2012). 
 
1.2.2.2 Transcriptional and epigenetic profiles 
EpiSCs also express the core pluripotency factors, Oct4, Sox2 and Nanog, although they 
have gene expression and epigenetic patterns that are distinct from ESCs (Nichols and 
Smith, 2009). In EpiSCs, Oct4 expression is controlled via its proximal enhancer (Yeom et 
al., 1996) and Nanog expression is decreased in comparison to ESCs (Gillich et al., 2012; 
Guo et al., 2009; Han et al., 2010). Consistent with in vivo development, expression of naïve 
state markers, such as Rex1, Stella, Nr0b1, Gbx2 and Klf4, is reduced or not detected in 
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EpiSCs, while the early post-implantation epiblast markers Fgf5, Otx2 and Oct6 are 
expressed (Brons et al., 2007; Tesar et al., 2007).  
Compared to 2iL ESCs, EpiSCs exhibit a more closed chromatin conformation 
(Hassan-Zadeh et al., 2017) and higher levels of DNA methylation (Auclair et al., 2014; 
Hackett et al., 2013; Veillard et al., 2014; Zylicz et al., 2015).  
Finally, random inactivation of one of the X-chromosomes occurs shortly after 
implantation in female epiblast cells and, correspondingly, female EpiSCs harbour one Xi 
(Bao et al., 2009; Guo et al., 2009).  
 
 Pluripotency and the status of X-chromosome 1.3
The fact that XCI is absolutely required for proper development of the mouse embryo, makes 
the presence of two Xa in female naïve pluripotent cells a striking feature. A link between XCI 
and cell differentiation has long been established and was first described based on 
biochemical analysis of X-linked enzymatic activities in early mouse embryonic stages (Monk 
and Harper, 1979). Cell culture studies corroborated this finding through observation of XCI 
during differentiation of both ECCs and ESCs (Martin et al., 1978; Rastan and Robertson, 
1985). The idea that XCI is coupled with cell differentiation was further reinforced by 
reprogramming experiments. Regardless of the method employed, reprogramming to the 
naïve pluripotent state is accompanied by reactivation of the X-chromosome and the 
resulting iPSCs display two Xa (Eggan et al., 2000; Maherali et al., 2007; Silva et al., 2009; 
Tada et al., 2001; Takagi et al., 1983). Remarkably, a study describing the sequence of 
epigenetic events of X-chromosome reactivation (XCR) during iPSC generation has reported 
that the reactivation of genes on the Xi is tightly correlated with the sequential activation of 
pluripotency-associated factors (Pasque et al., 2014). It has also been demonstrated that 
Nanog knockdown or Prdm14 knockout reduces the formation of iPSC colonies that display 
XCR (Pasque et al., 2014; Payer et al., 2013). 
The tight link of differentiation with XCI and acquisition of pluripotency with XCR was 
suggestive of a regulatory interaction between the pluripotency factor network and the genes 
at the Xic. Indeed, direct repression of Xist was proposed to occur through binding of 
pluripotency-associated factors OCT4, NANOG, SOX2 and PRDM14 to Xist intron 1 
(Navarro et al., 2008; Payer et al., 2013). The binding of the pluripotency-associated factors 
was found to be sharply reduced in differentiating ESCs and undetectable in fully 
differentiated mouse embryonic fibroblasts (Navarro et al., 2008). Moreover, downregulation 
of Oct4 and Nanog was found to induce moderate upregulation of Xist in male ESCs 
(Navarro et al., 2008) and the same effect was observed when the pluripotency factor 
binding site in Xist intron 1 was deleted in ESCs (Barakat et al., 2011; Nesterova et al., 
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2011). However, another study reported that deletion of intron 1 region both in ESCs and in 
mice did not impact Xist expression or XCI (Minkovsky et al., 2013), suggesting that there 
might be other elements ensuring that Xist is repressed in the context of naïve pluripotency. 
Therefore, it seems that Xist intron 1 is not required or that this region acts redundantly with 
other elements in the Xic. Furthermore, Xist was proposed to be directly repressed by REX1, 
which binds to the Xist promoter in ESCs and which is degraded during differentiation by the 
ubiquitin ligase RNF12 (Gontan et al., 2012). The Xist activator RNF12 is also bound by the 
pluripotency factors NANOG, OCT4, SOX2, KLF4 and PRDM14 (Navarro et al., 2011; Payer 
et al., 2013). PRDM14 was demonstrated to recruit PRC2 to repress Rnf12 in ESCs (Payer 
et al., 2013). Tsix also seems to be directly regulated by the naïve pluripotency network as 
shown by the stimulating effect that OCT4, REX1, KLF4 and c-MYC have on Tsix 
transcription through binding to the DXPas34 mini-satellite enhancer region associated with 
the Tsix promoter (Donohoe et al., 2009; Navarro et al., 2010).  
A further link between differentiation and XCI came from the finding that female ESCs 
with two Xa show a lower propensity for differentiation when compared to XY or XO ESCs, 
and that this can be overcome by inducing XCI (Schulz et al., 2014). Transcriptome analyses 
revealed that the two Xa stabilize the naïve pluripotent state via inhibition of the MAPK and 
GSK3 signalling pathways (Schulz et al., 2014). The authors suggested that this provides a 
likely explanation for the observation that in certain mammalian species female embryos 
develop more slowly than males. This suggests that the two Xa in epiblast cells of the pre-
implantation embryo interfere with differentiation, thus ensuring that development does not 
proceed without dosage compensation. 
 
 Scope of the study 1.4
In this study, I aimed to elucidate the relationship between naïve pluripotency and random 
XCI, using 2iL-cultured ESCs as the in vitro counterpart of the relevant developmental stage. 
 
Most studies investigating XCI have been performed using ESCs cultured in SL 
conditions which are known to be suboptimal (Chambers et al., 2007; Ficz et al., 2013; 
Habibi et al., 2013; Leitch et al., 2013; Marks et al., 2012; Martello and Smith, 2014). 2iL-
cultured ESCs display transcriptional and epigenetic signatures that resemble that of the 
naïve epiblast (Boroviak et al., 2014; Ficz et al., 2013; Hackett et al., 2017), meaning that 
they represent the cellular state of relevance for random XCI. According to the prevailing 
paradigm, ESCs express Xist at low levels, and after induction of differentiation, females 
upregulate Xist whereas males display repression of Xist (Sheardown et al., 1997). 
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In Chapter 3, I evaluated the levels of Xist in 2iL-cutured ESCs. Using both male and 
female 2iL-cultured ESCs as a model system, I explored the effect on Xist expression 
following the ablation of key components of the naïve pluripotency network. The experiments 
revealed that Xist is indeed not expressed in ESCs cultured in 2iL and that Xist expression is 
highly upregulated in the presence of a compromised naïve network, not only in females but 
also in males. These results prompted me to revisit the kinetics of Xist expression during 
male nPSC differentiation. In Chapter 4, I demonstrated that Xist is transiently and rapidly 
upregulated in early differentiating male cells. The data presented here indicate that 
downregulation of the naïve transcription factor network leads to upregulation of Xist and that 
this is independent of the gender. In Chapter 5, I characterised the nuclear pattern of Xist 
both in vitro and in vivo at different stages of embryonic development. I observed that early 
differentiating nPSCs accumulate Xist on the single male X-chromosome and on both female 
X-chromosomes, and that this is accompanied by appearance of a repressive chromatin 
signature and partial X-linked gene silencing. In the embryo, Xist is transiently expressed in 
males from the single X-chromosome and in females from both X-chromosomes at the onset 
of naïve epiblast differentiation. Altogether, these findings demonstrate that XCI initiation is 
gender-independent and is triggered by weakening of the naïve pluripotency network. 
 
15 
 
 Chapter 2 
Materials and methods 
 
 Cell culture 2.1
 Cell lines 2.1.1 
Male wild-type ESC lines included E14tg2a and EFC. Female wild-type ESC lines included 
LF1, LF2 and C6. The cell sorting experiment was performed in male Nanog-GFP ESCs. 
Female Nanog-GFP EpiSCs were used as control in Xist RNA FISH. Nanog deletion was 
performed in male and female Nanogflox/-, Rosa26CreERT2/+ ESC lines. Oct4 deletion was 
performed in male and female Oct4flox/-, Rosa26CreERT2/+ ESC lines. The male iPSC line used 
was derived from Rex1-dGFP NSCs. Reprogramming was performed in male Rex1-dGFP 
EpiSCs.  
 
 Culture media 2.1.2 
Mouse ESCs and iPSCs were cultured in 2iL, 2i, or SL as indicated. 2iL medium was 
composed of N2B27, 3 μM CHIR99021, 1 μM PD0325901 (Stewart lab, Dresden), and 20 ng 
ml−1 of murine LIF (Hyvonen lab, Cambridge). N2B27 medium comprised 1:1 DMEM/F-12 
and Neurobasal (ThermoFisher Scientific), 2 mM L-glutamine (ThermoFisher Scientific), 1X 
penicillin-streptomycin (Sigma-Aldrich), 0.1 mM 2-mercaptoethanol (ThermoFisher 
Scientific), 1% B27 (ThermoFisher Scientific) and 0.5% N2 (Stem Cell Institute, University of 
Cambridge). SL medium contained GMEM (Sigma-Aldrich), 10% FBS (Labtech), 1X NEAA 
(ThermoFisher Scientific), 1 mM sodium pyruvate (Sigma-Aldrich), 2 mM L-glutamine, 1X 
penicillin-streptomycin, 0.1 mM 2-mercaptoethanol and 20 ng ml−1 of LIF. EpiSCs were 
cultured in FAX medium composed of N2B27 supplemented with 12.5 ng ml−1 Fgf2, 20 ng 
ml−1 Activin A (Hyvonen lab, Cambridge) and 6.25 µg ml−1 XAV 939 (Bio-Techne). NSCs 
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were maintained in DMEM/F-12, 1x NEAA, 0.1 mM 2-mercaptoethanol, 1X penicillin-
streptomycin, 1% B27, 0.5% N2, 4.5 μM HEPES (ThermoFisher Scientific), 0.03 M glucose 
(Sigma-Aldrich), 120 μg ml-1 BSA (ThermoFisher Scientific),10 ng ml-1 Egf (Peprotech) and 
20 ng ml-1 Fgf2 (Department of Biochemistry, University of Cambridge). 4-OHT (Sigma-
Aldrich) was used at a concentration of 500 nM and InSolution JAKi I (Merck Millipore) at a 
concentration of 1 μM. During expansion of Nanogflox/- cell lines, selection with 200 μg 
ml−1 G418 (ThermoFisher Scientific) was applied to select for pluripotent cells based on 
Nanog promoter activity at the null allele.  
 
 Routine cell culture manipulations 2.1.3 
All cell lines were cultured in a humidified incubator at 37 °C and 7% CO2. ESCs and iPSCs 
were cultured on plastic pre-coated with 0.1% gelatin (Sigma-Aldrich) in PBS (Sigma-
Aldrich). EpiSCs were cultured on plastic pre-coated with 10 μg ml-1 fibronectin (Merck 
Millipore) in PBS (Sigma-Aldrich). NSCs were cultured on plastic pre-coated with 10 μg ml-1 
laminin (Sigma-Aldrich) in PBS (Sigma-Aldrich). PLAT-E cells were cultured on plastic 
without additional substrate. For passaging, cells were dissociated with TrypLE Express 
(ThermoFisher Scientific) if they were cultured in serum-containing medium or accutase 
(PAA Laboratories) if they were cultured in serum-free medium. After dissociation cells were 
centrifuged at 0.5 g for 3 minutes to remove the dissociating agent and replated at a required 
density in fresh media. All cell types were frozen in 10% DMSO (Santa Cruz Biotechnology) 
in serum-containing medium in a -80 ºC freezer. After 2 to 30 days, cryovials were 
transferred to a liquid nitrogen tank. 
 
 Cell differentiation 2.1.4 
For embryoid body differentiation, 1.5 x 106 cells were plated on 10 cm low-attachment 
dishes in serum-containing medium without LIF. For differentiation in adherent monolayer 
culture, 6 x 105 cells were plated on gelatin-coated 10 cm dishes in serum-free (N2B27) or 
N2B27 supplemented with FA. SL-derived ESCs (E14tg2a, EFC, LF1 and LF2) were not 
passaged more than 3 times in 2iL prior to the differentiation assays. 
 
 NSC reprogramming 2.1.5 
Retroviruses were produced by transfection of PLAT-E cells with pMXs-Klf4 and pMXs-cMyc 
plasmids (Addgene) using FuGENE 6 (Roche) according to manufacturer’s instructions. On 
day 2, virus-containing supernatants were filtered through 0.45 μm cellulose acetate filters 
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and mixed with Polybrene (Sigma-Aldrich) to a final concentration of 4 μg ml−1. 
Polybrene/virus mixture was applied to NSCs for 24 hours. Medium was switched to SL to 
generate reprogramming intermediates, followed by 2iL to obtain iPSCs. 
 
 EpiSC reprogramming 2.1.6 
Embryo-derived male EpiSCs with Rex1-dGFP reporter (Kalkan et al., 2017) were used that 
constitutively express the GY118F receptor transgene (Burdon et al., 1999), known to drive 
EpiSC reprogramming via STAT3 activation (van Oosten et al., 2012; Yang et al., 2010).  For 
reprogramming, EpiSCs were plated at 10,000 cells per fibronectin-coated 6-well in FAX 
maintenance medium. The following day, reprogramming was induced by medium change to 
2iL supplemented with 30 ng ml−1 human GCSF (Peprotech). On days 2, 3, 4, 5 and 6, 
multiple reprogramming wells were harvested using accutase, stained with DAPI (Sigma-
Aldrich) to eliminate nonviable cells, and sorted by flow cytometry to isolate the Rex1-dGFP-
positive subpopulation for further analysis. Parental EpiSCs and male Rex1-dGFP ESCs 
were used as negative and positive gating controls respectively. 
 
 ESC derivation 2.2
Nanogflox/flox, Rosa26CreERT2/CreERT2 mice were crossed with Nanog+/- and ESCs were derived 
from resultant E4.5 embryos. Embryos were removed from the uteri and plated on gelatin-
coated plates in 2iL medium. After 5-7 days of culture, the explants were passaged with 
accutase (PAA Laboratories) to a fresh plate. 
 
 NSC derivation 2.3
For derivation of Rex1-dGFP NSCs, brains of E13.5 embryos were dissected and 
mechanically dissociated by resuspending in NSC medium. Obtained single-cell suspension 
was plated onto laminin-coated cell culture dishes.  
 
 RNA isolation, cDNA synthesis and qRT-PCR 2.4
Total RNA was isolated from cells using the RNeasy mini kit (Qiagen) with DNAse treatment 
(Qiagen) in accordance with the manufacturer’s protocol. After purification, 1 µg of total RNA 
was reverse-transcribed using SuperScript III First-Strand Synthesis SuperMix 
(ThermoFisher Scientific). Reverse Transcription Quantitative Real-Time PCR (qRT-PCR) 
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reactions were set up in triplicate using TaqMan Universal PCR Master Mix (ThermoFisher 
Scientific) and TaqMan gene expression assays (ThermoFisher Scientific) (Table 2.1). qRT-
PCR experiments were performed in mircoAmp qPCR plates (ThermoFisher Scientific) on a 
StepOnePlus Real-Time PCR System (ThermoFisher Scientific). Each well contained 5 μL of 
cDNA, 6 μL TaqMan Fast Universal MasterMix (ThermoFisher Scientific), 0.6 μL VIC-labelled 
Gapdh probe for normalisation and 0.6 μL FAM-labelled probe of interest. Delta Ct (ΔCt) 
values compared to Gapdh were calculated and relative quantities calculated as 2 to the 
power of -ΔCt. The means of three values were calculated and normalised as indicated. 
 
Table 2.1 TaqMan qRT-PCR standard assays used in the study. 
Gene Probe ID 
Gapdh 4352339E 
Esrrb Mm00442411_m1 
Ftx Mm03455830_m1 
Klf2 Mm01244979_g1 
Klf4 Mm00516104_m1 
Klf5 Mm00456521_m1 
Nanog Mm02384862_g1 
Nexmif Mm01239465_g1 
Oct4 Mm00658129_gH 
Rex1 Mm03053975_g1 
Rnf12 Mm00488044_m1 
Socs3 Mm01249143_g1 
Sox2 Mm03053810_s1 
Tfcp2l1 Mm00470119_m1 
Xist Mm01232884_m1 
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 Flow cytometry 2.5
Nanog-GFP ESCs were resuspended in PBS containing 3.5% BSA (ThermoFisher Scientific) 
and sorting was performed using a MoFlo high-speed cell sorter (Beckman Coulter). A 
514/10BP filter was used for GFP and a 580/30BP filter was used for autofluorescence. 
Rex1-dGFP positive reprogramming intermediates were sorted using a BD Influx 5 cell sorter 
(BD Biosciences). A 460/50 filter was used for DAPI and a 530/40 filter was used for GFP. 
 
 DNA extraction 2.6
In the case of the cell lines, DNA was isolated using the DNeasy Blood & Tissue Kit (Qiagen) 
in accordance with the manufacturer’s protocol. In the case of the embryos, these were 
collected from the slides after RNA FISH and imaging and then lysed in 0.2% Triton X-100 
and Proteinase K at 56 ˚C for 10 minutes followed by 95 ˚C for 15 minutes. 
 
 Genotyping PCR 2.7
To determine whether ESCs were Nanogflox/- or Nanogflox/+, genotyping PCR was conducted 
in a final volume of 15 µL with 100 ng of DNA, 1X CoralLoad buffer, 0.2 mM dNTPs, 0.2 µM 
primers and 0.75 units Taq DNA Polymerase (Qiagen) per reaction and run on a thermal 
cycler with the following conditions: 94 ˚C for 5 minutes, 35 cycles of 94 ˚C for 10 seconds, 
60 ˚C for 20 seconds, and 72˚ C for 60 seconds, followed by 72 ˚C for 3 minutes. An equal 
mix of 3 primers was used: βgeo, S5, and A53 (Table 2.2). An 800 bp product is amplified 
from Flox and wild-type Nanog alleles, whereas the βgeo allele yields a 600 bp product. 
Products were electrophoresed on 2% agarose gel stained with 1:25,000 Midori Green 
(Nippon Genetics). The gel was run at 120 V using a Bio-Rad gel tank and bands were 
visualised using a UV light cabinet and GeneSnap software. 
 
 Gender PCR 2.8
Cell lines were sexed by PCR using primers Ube1XA and Ube1XB (Table 2.2) that results in 
two products of 217 bp and 198 bp from the Ube1x and Ube1y genes on the X- and Y-
chromosome respectively (Chuma and Nakatsuji, 2001). PCR reactions were performed in a 
final volume of 20 µL with 100 ng of DNA, 1X CoralLoad buffer, 0.2 mM dNTPs, 0.35 µM 
primers and 0.5 units Taq DNA Polymerase (Qiagen) per reaction and run on a thermal 
cycler with the following conditions: 94 ˚C for 3 minutes, 30 cycles of 94 ˚C for 30 seconds, 
66 ˚C for 30 seconds, and 72˚ C for 30 seconds, followed by 72 ˚C for 10 minutes. In the 
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case of the embryos, 4 µL per embryo lysate were added to the PCR reaction. Products were 
electrophoresed on 2% agarose gel stained with 1:25,000 Midori Green (Nippon Genetics). 
The gel was run at 120 V using a Bio-Rad gel tank and bands were visualised using a UV 
light cabinet and GeneSnap software. 
 
Table 2.2 Primers used in this study. 
Primer ID Sequence 
βgeo 5'-AATGGGCTGACCGCTTCCTC-3' 
S5 5'-ACCTCAGCCTCCAGCAGATG-3' 
A53 5'-CAGAATGCAGACAGGTCTACAGCCCG-3' 
Ube1XA 5'-TGGTCTGGACCCAAACGCTGTCCACA-3' 
Ube1XB 5'- GGCAGCAGCCATCACATAATCCAGATG-3' 
 
 Western blot 2.9
Dissociated cells were washed in PBS and resuspended in RIPA buffer containing 0.1% 
SDS, 1% Triton X-100, 1 mM EDTA, 1X Complete mini protease inhibitors (Roche) and 1X 
PhosSTOP phosphatase-inhibitors (Roche) in PBS. The suspension was incubated on ice for 
30 minutes and then sonicated with a Bioruptor200 sonicator (Diagenode) at high frequency 
for 3 minutes with alternating cycles of 30 seconds on and 30 sec off.  
Proteins were denatured by boiling for 10 minutes at 90 °C in 1X Bolt LDS sample 
buffer (ThermoFisher Scientific) with Bolt reducing agent (ThermoFisher Scientific). 
Denatured proteins were loaded onto a Bolt 10% Bis-Tris Plus gels (ThermoFisher Scientific) 
and SDS-PAGE electrophoresis was carried out by the application of 165 V at constant 
voltage in a Novex MiniCell (ThermoFisher Scientific) with 1X Bolt MOPS SDS running buffer 
(ThermoFisher Scientific). 
Protein transfer was performed using iBlot 2 dry blotting system (ThermoFisher 
Scientific) and iBlot Transfer Stacks (ThermoFisher Scientific) in accordance with the 
manufacturer’s protocol. The membrane was blocked for 1 hour in 5% skim milk (Sigma-
Aldrich) in 0.1% Tween 20/PBS. Primary antibody (Table 2.3) was diluted in 5% skim milk 
(Sigma-Aldrich) in 0.1% Tween 20/PBS and applied overnight at 4 °C. The membrane was 
washed three times in 0.1% Tween 20/PBS. In the case of p-Y705-STAT3, antibody dilutions 
were performed in 5% BSA (Sigma-Aldrich) in 0.1% Tween 20/TBS and washed in 0.1% 
Tween 20/TBS. 
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Table 2.3: Primary antibodies used for western blot. 
Against Species Clonality Dilution Cat number Company 
α-TUBULIN mouse monoclonal 1:5,000 AB7291 Abcam 
NANOG rabbit polyclonal 1:5,000 A300-397A 
Bethyl 
Laboratories 
p-Y705-STAT3 rabbit monoclonal 1:1,000 9145 
Cell Signalling 
Technology 
OCT4 goat polyclonal 1:1,000 SC-8628 
Santa Cruz 
Biotechnology 
RNF12 rabbit polyclonal 1:1,000 ABE1949 Merck Millipore 
 
Horseradish peroxidase (HRP)-conjugated secondary antibodies (Table 2.4) were 
diluted at a concentration of 1:10,000 in 5% skim milk in 0.1% Tween 20/PBS and then 
applied for 1 hour at room temperature. The membrane was washed three times in 0.1% 
Tween 20/PBS and once in PBS before being treated with ECL Plus Western Blotting 
Detection System (GE Healthcare) and used to expose photographic film in a darkroom. 
 
Table 2.4: Secondary antibodies used for western blot. 
Against Species Cat number Company 
Mouse sheep NA931 GE Healthcare 
Rabbit donkey NA934 GE Healthcare 
Goat donkey sc-2020 
Santa Cruz 
Biotechnology 
 
 RNA FISH with double-strand probe 2.10
Cells were plated on SuperFrost Plus Adhesion slides (ThermoFisher Scientific) and 
permeabilised in cytoskeletal buffer (100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 10 mM 
PIPES) containing 0.5% Triton X-100 (Sigma-Aldrich), 1 mM EGTA pH 8 and vanadyl 
ribonucleoside (New England Biolabs) for 5 minutes on ice. They were subsequently fixed in 
4% paraformaldehyde (Sigma-Aldrich) for 10 minutes, briefly washed in 1X PBS and 
dehydrated through 70%, 80%, 95% and 100% ethanol, after which the slides were air-dried. 
At this stage, a denatured Xist probe was applied onto the slides and these were incubated 
overnight at 37 °C.  
The probe was prepared by labelling plasmid DNA containing a mouse Xist exon 1 
fragment sequence (provided by Professor Neil Brockdorff, University of Oxford, UK) with a 
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biotin-nick translation mix (Roche) according to manufacturer’s instructions. Non-
incorporated nucleotides were removed using with an S-300HR Illustra microspin column 
(GE Healthcare). To 20 ng of probe, 10 μg of sheared salmon sperm DNA (Ambion) and 3 
μg of mouse Cot-1 DNA (ThermoFisher Scientific) were added. Finally, the probe was 
dehydrated by vacuum and resuspended in deionized formamide (VWR). Before applying 
onto the slide, the probe was denatured at 80 °C and 2X hybridization buffer (4X SSC, 20% 
dextran sulphate, 2 mg ml-1 BSA, 2 mM vanadyl ribonucleoside) was added.  
The following day, the slides were washed at 42 °C in 2X SSC/50% formamide for 15 
minutes, then three times in 2X SSC for 5 minutes each. They were then transferred to 4X 
SSC/0.1% Tween 20 at room temperature and blocked in 4 mg ml-1 BSA in 4X 
SSC/0.1%Tween 20 at 37 °C for 30 minutes. Probe detection was performed by first applying 
Avidin conjugated to Texas Red (1:500, Vector Laboratories), then a biotinylated anti-avidin 
antibody (1:200, Vector Laboratories), followed by a second layer of Avidin-Texas Red. All 
detection reagents were diluted in 4 mg ml-1 BSA in 4X SSC/0.1%Tween 20 and incubated at 
37 °C for 30 minutes followed by three washes in 4X SSC/0.1% Tween20 in between each 
step. Finally, the slides were mounted in Vectashield Mounting Medium containing DAPI 
(Vector Laboratories). 
 
 RNA FISH with single-strand probe 2.11
RNA FISH protocol was modified from the Stellaris (Biosearch Technologies) protocol for 
adherent mammalian cells. Cells were plated on SuperFrost Plus Adhesion slides 
(ThermoFisher Scientific) and fixed in 4% PFA (Sigma-Aldrich) at room temperature for 10 
minutes. They were subsequently washed in 1X PBS and permeabilised in cytoskeletal 
buffer (100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 10 mM PIPES) containing 0.5% Triton 
X-100, 1 mM EGTA pH 8 and vanadyl ribonucleoside (New England Biolabs) for 5 minutes 
on ice. Following washing in 1X PBS, they were incubated in 70% ethanol at 4 °C overnight. 
Cells were incubated in 10% formamide (VWR) in 2X SSC (Sigma-Aldrich) for 10 minutes 
and then overnight in 250 nM Stellaris Probes diluted in 100 mg mL−1  dextran sulfate (MP 
Biomedicals) and 10% formamide in 2X SSC at 37 °C. Xist was recognised using Stellaris 
FISH Probes labelled with either Quasar 570 or Quasar 670 (BioSearch 
Technologies). Rnf12, Nexmif, Huwe1, Nsdhl and Wbp5 were recognised using Custom 
Stellaris FISH Probes labelled with Quasar 570 (BioSearch Technologies). The sequences of 
48 oligonucleotides were designed against unique intronic sequences using the online 
Stellaris Probe Designer tool (BioSearch Technologies). The Rnf12 and Huwe1 probes 
sequences were kindly provided by Prof. Neil Brockdorff and Dr. Tatyana Nesterova 
(University of Oxford, UK). After hybridisation, cells were incubated in 10% formamide in 2X 
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SSC at 37 °C for 30 minutes followed by a wash in 2X SSC at room temperature for 5 
minutes. Cells were mounted with Vectashield Antifade Mounting Medium with DAPI (Vector 
Laboratories). 
 
 RNA FISH on mouse embryos 2.12
Mouse embryos were collected from CD1 mice and fixed in 4% paraformaldehyde at room 
temperature for 15 minutes. Embryos were further processed for RNA FISH using Stellaris 
probes (BioSearch Technologies) according to the procedure described above. 
 
 Immunofluorescence 2.13
Immunofluorescence was always performed in combination with RNA FISH using Stellaris 
probes. Sequential immunofluorescence and RNA FISH protocol was modified from the 
Stellaris (BioSearch Technologies) protocol for adherent mammalian cells. Cells were fixed 
and permeabilised as for RNA FISH only. They were then washed in 1X PBS and incubated 
with primary antibody (Table 2.5) diluted in 1X PBS at 37 °C for 2 hours. Following washing 
three times in 1X PBS, cells were incubated with secondary antibody (Table 2.6) diluted at 
1:5,000 in 1X PBS at 37 °C for 1 hour. An appropriate Alexa Fluor conjugated secondary 
antibody (ThermoFisher Scientific) was used. Cells were then washed three times in 1X PBS 
and fixed again in 4% PFA at room temperature for 10 minutes. Following washing with 1X 
PBS, RNA FISH protocol was carried out as described above, starting from the incubation in 
10% formamide in 2X SSC. 
 
Table 2.5: Primary antobodies used for immunofluorescence. 
Against Species Clonality Dilution Cat number Company 
H3K27me3 rabbit polyclonal 1:500 07-449 Merck Millipore 
H3K27ac rabbit polyclonal 1:500 ab4729 Abcam 
NANOG rat monoclonal 1:300 14-5761-80 
ThermoFisher 
Scientific 
OCT4 rabbit monoclonal 1:300 83932 
Cell Signalling 
Technology 
Cleaved 
CASPASE-3 
rabbit monoclonal 1:100 9664 
Cell Signalling 
Technology 
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Table 2.6: Secondary antibodies used for immunofluorescence. 
Against Species Wavelength Cat number Company 
Rabbit Donkey 488 nm A-21206 ThermoFisher Scientific 
Rabbit Donkey 647 nm A-31573 ThermoFisher Scientific 
Rat Donkey 488 nm A-21208 ThermoFisher Scientific 
 
 Metaphase spread 2.14
ESCs were plated onto a gelatinised 6-well two days prior preparation of the chromosome 
spreads. Cultures were then arrested in metaphase by addition of 0.5 µg mL−1 KaryoMAX 
colcemid (ThermoFisher Scientific) and incubation at 37 °C for 3 hours. Cells were then 
washed in PBS, harvested with accutase and centrifuged at 300 g for 5 minutes. Following 
aspiration of the supernatant, the pellet was resuspended in 5 mL of 0.075 M KCl solution 
and incubated at 37 °C for 15 minutes. Then 100 µL of ice cold methanol:glacial acetic acid 
(3:1) fixative solution were added drop-wise followed by a 10-minute incubation on ice. 
Following incubation, cells were centrifuged at 300 g for 5 minutes, supernatant was 
aspirated leaving 500 µL in the tube and 5 mL of fixative solution were added to the cells. 
After centrifugation, 500 µL of the supernatant were kept in the tube and then spread onto a 
glass slide. After at least 3 hours at room temperature, the slide was stained or stored at -20 
°C for further analysis.   
 
 DNA FISH chromosome painting 2.15
Prior to X- and Y-chromosome painting, immunofluorescence was performed in combination 
with RNA FISH, slides were imaged and x-y coordinates were marked for future reference. 
After removal of the coverslip, slides were then washed in 2X SSC at room temperature. X- 
and Y-chromosome painting was also performed on metaphase spreads. Slides were 
dehydrated through an ice-cold ethanol series (70%, 80%, 95% and 100%) for 3 minutes 
each and then allowed to air dry. X- and/or Y-chromosome paint probe (Metasystems) was 
added to the slide, denaturation was carried out at 75 °C for 2 minutes and slides were 
incubated at 37 ˚C overnight. After hybridisation, slides were incubated in 0.4X SSC at 72 ˚C 
for 2 minutes followed by a wash with 0.05% Tween 20 in 2X SSC at room temperature for 
30 seconds. Slides were rinsed in water, allowed to air dry and mounted with Vectashield 
Antifade Mounting Medium with DAPI (Vector Laboratories). 
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 Microscopy and image analysis 2.16
Images were taken with an Eclipse Ti Spinning Disk confocal microscope (Nikon) equipped 
with an Andor Revolution XD System using either 40X or 60X objectives. Images were 
processed and analysed with ImageJ. Presented images are maximum intensity projections 
of Z-stack slices. Scoring of RNA FISH signals was done by eye from images. 
 
 RNA-seq 2.17
RNA integrity was assessed on a Qubit Fluorometer (ThermoFisher Scientific) and Agilent 
Bioanalyzer Nano Chips (Agilent Technologies). Depletion of ribosomal RNA was performed 
on 2-5 μg of total RNA using the Ribo-Zero rRNA Removal Kit (Illumina) and libraries were 
produced from 10-100ng of ribosomal-depleted RNA using NextFlex Rapid Directional RNA-
seq Kit (Bioo Scientific) with 12 cycles of PCR amplification. Libraries were pooled in 
equimolar quantities and sequenced on the HiSeq4000 platform (Illumina) at CRUK.  
 
 Bioinformatic analysis of RNA-seq 2.18
RNA-seq reads were adapter-trimmed with TrimGalore (http://www.bioinformatics.babraham.
ac.uk/projects/trim_galore) and mapped to the mouse reference genome (GRCm38/mm10) 
with TopHat2 (https://ccb.jhu.edu/software/tophat) allowing for one mismatch and alignments 
guided by Ensembl gene models (Ensembl release 82). Strand-specific read counts were 
obtained with featureCounts (http://bioinf.wehi.edu.au/featureCounts). Transcript counts were 
normalised, and the statistical significance of differential expression between samples was 
assessed using the R Bioconductor DESeq2 package (https://bioconductor.org/packages
/release/bioc/html/DESeq2.html). Transcript counts normalised by DESeq2 size factors were 
subsequently normalised by their length/1000.  Principal component analysis (PCA) was 
performed by singular value composition using the R prcomp() function on scaled expression 
values. 
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 Chapter 3 
Understanding the link between naïve pluripotency and 
Xist status 
 
 Introduction 3.1
According to the literature, both female and male SL-cultured ESCs express Xist at low 
levels, which can be detected by RNA FISH as two pinpoint signals in the case of female 
cells or one in male cells (Panning et al., 1997; Sheardown et al., 1997). As female ESCs 
differentiate, Xist is upregulated monoallelically and coats the inactivating X-chromosome 
(Panning et al., 1997; Sheardown et al., 1997). This temporal correlation between 
differentiation and XCI led to the idea that pluripotency factors may play a role in the 
regulation of this process. Indeed, there have been several reports describing the regulation 
of Xist and other members of the Xic by pluripotency factors (Donohoe et al., 2009; Navarro 
et al., 2008; Navarro et al., 2011; Navarro et al., 2010; Nesterova et al., 2011; Payer et al., 
2013; Silva et al., 2009). However, these studies have largely been conducted in vitro and 
using ESCs cultured in SL conditions, an environment in which repression of any of the naïve 
pluripotency factors would induce collapse of the naïve network and consequent 
differentiation. Moreover, SL conditions are known to be suboptimal. SL-cultured ESCs 
exhibit transcriptional heterogeneity of pluripotency factors (Chambers et al., 2007), 
increased expression of lineage markers (Marks et al., 2012), reduced strength of the naïve 
network (Martello and Smith, 2014), and high DNA methylation levels that are comparable to 
those observed in somatic cells (Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 2013). 
Remarkably, using defined serum-free 2iL medium these limitations have been overcome 
(Silva et al., 2008; Silva et al., 2009; Ying et al., 2008). In addition, ESCs cultured in 2iL 
exhibit transcriptional and epigenetic signatures that resemble that of E4.5 epiblast (Boroviak 
et al., 2015; Ficz et al., 2013; Hackett et al., 2017). Importantly, this means that, unlike SL 
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ESCs, 2iL ESCs are the appropriate epigenetic counterpart to the naïve epiblast, the starting 
identity from which random XCI occurs. 
 
 Aims of the chapter 3.1.1 
It is unknown whether increased transcriptional homogeneity and naïve pluripotency network 
robustness have an impact on Xist status. Moreover, the effect of the repression of naïve 
pluripotency factors on Xist expression in the context of naïve pluripotency is still unclear. 
Therefore, I aimed to characterise the status of Xist expression in nPSCs and to study the 
relationship of naïve cell identity and Xist status by making use of nPSC culture conditions 
that increase the strength of the naïve transcriptional network and allow the removal of key 
components of the naïve network without induction of differentiation. 
 
 Results 3.2
 Robust nPSC self-renewal abolishes Xist expression  3.2.1 
To evaluate the impact of increased naïve pluripotency gene expression homogeneity and 
robustness on the levels of Xist, I used two female and two male ESC lines as a model. First, 
the gender of these cell lines was confirmed by genomic PCR (Figure 3.1A). Additionally, 
DNA FISH with X- and Y-chromosome painting probes was performed on metaphase 
spreads of one female and one male ESC line. The male cell line revealed a normal 40, XY 
karyotype in virtually all cells analysed, whereas the female cell line presented a 40, XX 
karyotype in a very high proportion of the cells (Figure 3.1B). The four ESC lines, which had 
been previously derived in SL conditions, were transferred to 2iL conditions and analysed 
before and after passaging in 2iL (Figure 3.1C). As a consequence of transferring the cells 
from SL to 2iL, upregulation of naïve pluripotency factors was observed (Figure 3.1D). This is 
in agreement with previous studies showing that exogenous 2iL signals actively interact with 
the internal transcription factor network leading to augmented expression of its members 
(Martello and Smith, 2014).  
Concomitantly with the upregulation of naïve pluripotency factors, 2iL conditions led 
to repression of Xist in both male and female ESCs (Figure 3.1D). Remarkably, only one 
passage in 2iL was required for Xist expression to be extinguished.  
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Figure 3.1: Xist expression is repressed by a robust naïve pluripotency network. 
(A) PCR-based sex determination of the cell lines LF1 (XX1), LF2 (XX2), E14tg2a (XY1), and 
EFC (XY2).  
(B) DNA FISH with X (green) and Y (red) chromosome painting probes of metaphase 
spreads of the ESC lines XX1 and XY1.  
(C) Schematic illustrating the experiment performed to evaluate the impact of the nPSC 
culture conditions on Xist expression.  
(D) qRT-PCR analysis of naïve pluripotency factors (Nanog, Esrrb, Klf4, Klf2, and Tfcp2l1) 
and Xist in XX1, XX2, XY1, and XY2 ESC lines in SL versus 2iL conditions. P indicates the 
number of passages in 2iL. Data shown are the mean of three technical replicates. Error bars 
represent ± SD.  
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ESCs in SL present heterogeneous levels of naïve pluripotency factors (Chambers et 
al., 2007) rendering these cells a useful tool to study the relationship between naïve network 
status and Xist expression. Male SL ESCs harbouring a Nanog-GFP reporter were FACS-
sorted into low, medium, and high GFP populations (Figures 3.2A and 3.2B). The correlation 
between the levels of GFP and Nanog expression was confirmed by qRT-PCR (Figure 3.2C). 
Importantly, Oct4 was expressed at high levels in all the three fractions showing that these 
cells do not seem to be exiting pluripotency despite the heterogeneity of Nanog expression 
levels. As expected, the pluripotency factor Klf4, which has been shown to be regulated by 
Nanog (Stuart et al., 2014), positively correlated with Nanog expression. Interestingly, 
Nanog-high cells exhibited 28-fold lower Xist expression levels than Nanog-low cells (Figure 
3.2C). These results suggest that the increased Xist expression observed when the cells are 
cultured in SL are a consequence of the pluripotency-associated transcriptional 
heterogeneity observed in these culture conditions. 
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Figure 3.2: Xist expression is heterogeneous in SL-cultured nPSCs.  
(A) PCR-based sex determination of the Nanog-GFP ESC line.  
(B) Flow cytometry analysis of male SL Nanog-GFP ESCs and subsequent sorting into three 
Nanog-GFP populations: low, medium, and high.  
(C) qRT-PCR analysis of Nanog, Klf4, Oct4, and Xist in low, medium and high Nanog-GFP 
ESCs. Data shown are the mean of three technical replicates. Error bars represent ± SD. 
 
 
 
 
 
 
 
 
 
 
 
 
  
32 
 
To validate the qRT-PCR data showing that Xist is not expressed in nPSCs, RNA-seq 
was performed in male 2iL-cultured nPSCs. I would like to highlight that RNA-seq was 
strand-specific so expression of Xist could be distinguished from expression of its antisense 
RNA Tsix. Importantly, RNA-seq data corroborated the qRT-PCR results showing that Xist is 
repressed in male 2iL nPSCs (Figure 3.3A). The results clearly demonstrate that expression 
at the Xist locus is exclusively antisense (Figure 3.3A).  
I then analysed the pattern of Xist RNA using both a single-strand Xist-specific probe 
and a conventional double-strand probe detecting Xist exon 1 and also Xist antisense 
transcript. When using the double-strand probe, most male and female cells analysed 
exhibited one or two pinpoint signals, respectively (Figure 3.3B). This is in agreement with 
previous studies in which Xist double-strand probe was used (Panning et al., 1997; 
Sheardown et al., 1997). In contrast, Xist was detected in less than 2% of the cells when the 
strand-specific probe was used. These results indicate that the pinpoint signals observed 
with the double-strand probe correspond to expression antisense to Xist (Figure 3.3B). To 
confirm that the single-strand probe successfully detects Xist expression, a female EpiSC 
line was analysed. Female EpiSCs have one Xi and, therefore, one Xist cloud per cell was 
observed (Figures 3.3B and 3.3C). 
 
Altogether, these data demonstrate that Xist is not expressed in robust self-renewing 
nPSCs. It also highlights that previous publications reporting Xist expression in nPSCs must 
be considered with caution, due to the confounding detection of Tsix with the conventionally 
used double-strand probe. 
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Figure 3.3: Xist is undetectable in nPSCs by either strand-specific RNA-seq or RNA 
FISH.  
(A) Strand-specific RNA-seq showing expression of Tsix (positive strand) and Xist (negative 
strand) in male (XY1) 2iL ESCs. The double-strand Xist probe used in (B) is represented in 
red. The RNA-seq analysis was performed by Dr. Sabine Dietmann and Dr. 
Mohammadmersad Ghorbani.  
(B) RNA FISH in male (XY1) and female (XX1) 2iL ESCs with a double-strand probe 
(indicated as ds) detecting both Xist and Tsix (left) or with a single-strand probe (indicated as 
ss) detecting only Xist (right). Nuclei are shown in blue (DAPI staining). The percentage of 
cells with Xist signal is indicated. Female EpiSCs were used as a control for the single-strand 
probe. The scale bar represents 5 μm.  
(C) PCR-based sex determination of the control EpiSC line. 
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 Analysis of Xist status in nPSCs upon Nanog deletion 3.2.2 
Having established by different methods that Xist is not expressed in 2iL nPSCs, I decided to 
further investigate the relationship between naïve pluripotency network and Xist status using 
2iL conditions. It has been reported that 2iL culture medium allows the removal of 
components of the naïve transcription factor network that otherwise would be essential (Ying 
et al., 2008). Therefore, I aimed to analyse Xist expression following withdrawal of some of 
these factors in the context of pluripotency. Navarro and colleagues used SL-cultured ESCs 
to show that Nanog, one of the core components of the naïve network, was implicated in the 
regulation of Xist (Navarro et al., 2008). In order to revisit this finding, we first derived ESCs 
in 2iL that would allow us to perform Nanog conditional knockout. Mice homozygous for a 
Nanog conditional allele (Nanogflox/flox) (Chambers et al., 2007) and expressing CreERT2 
ubiquitously from the Rosa26 locus were crossed with Nanog heterozygous mice (Nanog+/-) 
(Mitsui et al., 2003) (Figure 3.4A). ESCs were derived from the resulting Nanogflox/+, 
Rosa26CreERT2/+ and Nanogflox/-, Rosa26CreERT2/+ E4.5 embryos (Figure 3.4A). After determining 
the genotype and sex of each cell line, two of the Nanogflox/- lines, one female (number 15) 
and one male (number 10), were selected for subsequent experiments (Figures 3.4B and 
3.4C). The Nanogflox/-, Rosa26CreERT2/+ ESCs were then treated with 4-hydroxytamoxifen (4-
OHT) to excise LoxP-flanked exons and bring GFP under control of the Nanog promoter. 
This resulted in Nanog-/- GFP-expressing ESCs that were harvested at different time points 
for analysis (Figures 3.4D and 3.4E).    
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Figure 3.4: Strategy for Nanog conditional knockout.  
Legend continues on next page. 
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Deletion of Nanog was confirmed at the protein level by western blot. NANOG levels 
were already diminished after 6 hours of treatment and barely detectable 48 hours post-
treatment (Figure 3.5A). Strikingly, Xist was highly upregulated at 72 hours post-treatment 
with 4-OHT in both female and male cells (Figure 3.5B). As expected, Nanog deletion also 
had an effect on the expression of its downstream targets, such as Klf4 (Stuart et al., 2014) 
and Esrrb (Festuccia et al., 2012), but not on Oct4 or other naïve pluripotency genes (Figure 
3.5C). The fact that the levels of pluripotency markers, like Oct4 and Sox2, remain 
unchanged shows that despite Nanog deletion these cells remain naïve pluripotent, 
consistent with the ability of Nanog-/- ESCs to be generated and maintained (Chambers et al., 
2007). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Strategy for Nanog conditional knockout.  
(A) Simplified schematic of the strategy used to generate Nanogflox/+ and Nanogflox/- ESCs, not 
to scale. All alleles are under control of the endogenous Nanog promoter, and the Nanog 5’ 
UTR is unchanged. Nanogflox/flox, Rosa26CreERT2/CreERT2 mice were crossed with Nanog+/- and 
the resulting E4.5 embryos were derived into ESCs. Key: endogenous Nanog exons (1, 2, 3, 
4); splice-acceptor (SA); internal ribosome entry site (IRES); geneticin resistance (βgeo); 
stop codon (S); LoxP site (L); puromycin resistance (Pac); GFP coding sequence without a 
promoter (GFP). These cell lines were derived in collaboration with Prof. Jennifer Nichols.  
(B) Genotyping of the ESC lines obtained from the cross represented in (A).  
(C) PCR-based sex determination of the ESC lines obtained from the cross represented in 
(A). Cell lines number 10 and number 15 were used to carry out the subsequent 
experiments.  
(D) Schematic illustrating the approach employed to delete Nanog from ESCs. Nanogflox/-, 
Rosa26CreERT2/+ were treated with 4-OHT to excise LoxP-flanked Nanog exons and bring GFP 
under control of the Nanog promoter. This resulted in Nanog-/- GFP-expressing ESCs that 
were harvested at the indicated time points for analysis.  
(E) Phase and GFP images of the Nanogflox/-, Rosa26CreERT2/+ ESCs before and after 24 hours 
(h) of treatment with 4-OHT. The 4-OHT-treated cells express GFP indicating that the 
deletion was successful. 
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Figure 3.5: Nanog deletion leads to Xist upregulation in the context of naïve 
pluripotency.  
(A) Western blot analysis of NANOG in female and male Nanogflox/-, Rosa26CreERT2/+ ESCs in 
2iL (0 hours) and at different time points following treatment with 4-OHT.  
(B) qRT-PCR analysis of Nanog and Xist in female and male Nanogflox/-, Rosa26CreERT2/+ 
ESCs in 2iL (0 hours) and at different time points following treatment with 4-OHT. Data 
shown are the mean of three technical replicates. Error bars represent ± SD.  
(C) qRT-PCR analysis of naïve markers (Esrrb, Klf4, Klf5, Sox2, Tfcp2l1, Rex1, and Oct4) in 
female and male Nanogflox/-, Rosa26CreERT2/+ ESCs in 2iL (0 hours) and at different time points 
following treatment with 4-OHT. Data shown are the mean of three technical replicates. Error 
bars represent ± SD. 
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 Impact of JAK/STAT3 signalling inhibition on the expression of Xist 3.2.3 
JAK/STAT3 signalling plays an important role in the maintenance of pluripotency (Burdon et 
al., 1999; Matsuda et al., 1999). Moreover, activated STAT3 (p-STAT3) and its downstream 
target genes have binding sites within the XIC that harbours Xist and other genes involved in 
its regulation (Sanchez-Castillo et al., 2015). Thus, I examined the impact of JAK/STAT3 
signalling inhibition on Xist expression in nPSCs. Inhibition of JAK/STAT3 signalling was 
achieved by treatment of ESCs with a JAK inhibitor (JAKi) that has inhibitory activity against 
all members of the JAK family – JAK1, JAK2, JAK3, and TYK2. Since LIF signals via JAKs 
and induces activation of STAT3 (Niwa et al., 1998), treatment with JAKi was performed in 
the absence of LIF. Treated ESCs (1µM JAKi + 2i) were compared with ESCs cultured in 
either 2iL or 2i, both of which maintain naïve pluripotency (Dunn et al., 2014). Cells were 
analysed at 0, 3, and 5 days post-treatment (Figure 3.6A). This experiment was carried out in 
both female and male ESCs (Figures 3.1A and 3.6B). JAK/STAT3 inhibition was confirmed 
through depletion of p-STAT3 (Figure 3.6C) and downregulation of its downstream target 
Socs3 (Figure 3.6D). 
Interestingly, treatment with 1 µM JAKi induced a striking upregulation of Xist in both 
female and male ESC lines (Figure 3.7). However, ESCs treated with JAKi demonstrated 
diminished expression of certain pluripotency factors, such as Oct4 (Figure 3.8A), which are 
known to be required for the integrity of the pluripotency network. Moreover, there were loss 
of the characteristic ESC morphology and decreased self-renewal capacity of ESCs in the 
presence of JAKi (Figure 3.8B). 
Together, these observations suggest that, when treated with 1 µM JAKi, ESCs 
appear to initiate exit from naïve pluripotency. This is in agreement with a previous report 
showing that Stat3-/- ESCs can be generated in 2i but are prone to differentiation (Carbognin 
et al., 2016). The results were particularly surprising in the case of male cells because 
according to the literature naïve identity loss is accompanied by inhibition of Xist in males 
(Panning et al., 1997; Sheardown et al., 1997). Nevertheless, our data revealed a 
surprisingly high upregulation of Xist not only in females but also in males upon treatment 
with JAKi and consequent apparent exit from the naïve state. 
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Figure 3.6: Strategy for inhibition of JAK/STAT3 signalling in nPSCs.  
(A) Schematic of the time course performed with JAKi to deplete JAK/STAT3 signalling from 
ESCs.  
(B) PCR-based sex determination of the C6 (XX3) ESC line.  
(C) Western blot analysis of p-STAT3 in female (XX3) and male (XY1) ESCs in 2iL, 2i or 
after 3 days in 1µM JAKi + 2i.  
(D) qRT-PCR analysis of the STAT3-target Socs3 in female (XX3) and male (XY1) ESCs in 
2iL, 2i or after 3 and 5 days in 1µM JAKi + 2i. Data shown are the mean of three technical 
replicates. Error bars represent ± SD. 
 
Figure 3.7: Inhibition of JAK/STAT3 induces upregulation of Xist.  
qRT-PCR analysis of Xist in female (XX3) and male (XY1) ESCs in 2iL, 2i or after 3 and 5 
days in 1µM JAKi + 2i. Data shown are the mean of three technical replicates. Error bars 
represent ± SD. 
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Figure 3.8: ESCs treated with JAKi appear to be exiting from naïve pluripotency. 
(A) qRT-PCR analysis of the naïve markers (Nanog, Oct4, Sox2, Tfcp2l1, Klf4, Klf5, and 
Esrrb) in female (XX3) and male (XY1) ESCs in 2iL, 2i or after 3 and 5 days in 1µM JAKi + 
2i. Data shown are the mean of three technical replicates. Error bars represent ± SD.  
(B) Phase images of ESCs in 2i before and after treatment with 1µM JAKi. 
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 Discussion 3.3
In this chapter, I reported that Xist is fully repressed in both male and female nPSCs 
provided they have a robust naïve transcription factor network. This can be achieved through 
the use of optimal nPSC culture conditions, like 2iL medium. It had been previously shown 
that Xist expression is decreased in 2i conditions when compared to SL (Marks et al., 2015). 
However, using strand-specific RNA-seq and RNA FISH allowed me to find that Xist is 
indeed not expressed in 2iL-cultured nPSCs. I speculate that the RNA antisense to Xist was 
responsible for the expression levels detected in nPSCs in previous studies employing 
methods that do not enable the distinction between the two strands. Given the resemblance 
between 2iL nPSCs and the E4.5 mouse naïve pluripotent epiblast (Boroviak et al., 2015), I 
hypothesise that Xist is also not expressed in the epiblast at this stage. This will be 
investigated further in this dissertation. 
Repression of Xist in nPSCs may be the result of a combination of direct and indirect 
mechanisms taking place at the Xic. It has been reported that Xist and other non-coding and 
coding genes involved in its regulation harbour multiple genomic binding sites that are 
occupied by naïve pluripotency-associated transcriptions factors (Sanchez-Castillo et al., 
2015). Moreover, there have been some studies reporting the regulation of members of the 
Xic, including Xist, by pluripotency factors (Donohoe et al., 2009; Navarro et al., 2008; 
Navarro et al., 2011; Nesterova et al., 2011; Payer et al., 2013; Silva et al., 2009). Regulation 
of Xist by both NANOG and OCT4 was proposed to occur through binding to Xist intron 1 
and spatial association with the Xist promoter (Navarro et al., 2008). Additionally, deletion of 
Xist intron 1 in female or male ESCs induced a moderate upregulation of Xist expression 
(Nesterova et al., 2011). However, in a different study deletion of intron 1 region both in 
ESCs and in mice did not significantly impact Xist expression (Minkovsky et al., 2013). 
Therefore, although there is strong evidence that the pluripotency network plays a role in the 
regulation of Xist, it seems that this relationship does not rely on Xist inton 1. 
Here, I made use of 2iL-cultured nPSCs to achieve deletion of Nanog without losing 
the naïve pluripotent identity of the cells and then study the impact of Nanog deletion on Xist 
status. Upregulation of Xist in this context was much more striking than that observed when 
the cells were cultured in SL (Navarro et al., 2008). This may be explained by the 
homogeneity of the nPSCs cultured in 2iL and also by the fact that Xist is repressed in these 
culture conditions. As expected, deletion of Nanog in 2iL conditions did not promote exit from 
naïve pluripotency. The effect of JAK/STAT3 inhibition on Xist expression was similar to that 
observed when Nanog was deleted: striking upregulation of Xist in both male and female 
cells. However, treatment with JAKi induced exit of nPSCs from the naïve state as indicated 
by changes in cell morphology and downregulation of pluripotency markers, like Oct4. 
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According to the literature, differentiation of male ESCs is accompanied by inhibition of Xist 
(Panning et al., 1997; Sheardown et al., 1997). Therefore, it was very surprising to observe 
increased expression of Xist in male cells that seem to be exiting the naïve pluripotent state. 
These results prompted me to revisit the kinetics of Xist expression during male nPSC 
differentiation. 
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 Chapter 4 
Investigating the relationship between loss of naïve cell 
identity and Xist expression 
 
 Introduction 4.1
Female mouse nPSCs contain two Xa and undergo random XCI upon induction of 
differentiation (Penny et al., 1996), making these cells a very useful tool to study this 
process. During differentiation of female nPSCs, one of the two X-chromosomes is randomly 
chosen for inactivation and Xist is upregulated from the future Xi. In contrast, Xist is thought 
to be repressed as male nPSCs exit from naïve pluripotency and undergo differentiation 
(Panning et al., 1997; Sheardown et al., 1997). Intriguingly, the results from Chapter 3 show 
that, in the presence of a naïve network that appears to have been compromised, Xist is 
highly upregulated not only in female but also in male cells. However, it remained to be 
elucidated whether Xist upregulation in males is due to a weaker but nonetheless naïve 
identity or a consequence of naïve cell differentiation.  
Although several models have been proposed, it is still a mystery how the cell 
ensures that there is always one Xa per diploid genome (Goodrich et al., 2016). Moreover, it 
is not clear yet how the cell distinguishes whether it is male or female and whether or not XCI 
should be triggered. Therefore, I hypothesised that the rapid collapse of the naïve 
pluripotency network may impact the expression of Xist in both male and female cells before 
gender-specific mechanisms take place. 
 
 Aims of the chapter 4.1.1 
In the previous chapter, I have demonstrated that the nPSC culture conditions impact on the 
expression and nuclear pattern of Xist. Moreover, the results showed that male cells that 
seem to be exiting from the naïve state display highly increased Xist expression. Therefore, I 
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aimed to study the kinetics of Xist expression during differentiation of both male and female 
2iL-cultured nPSCs. 
 
 Results 4.2
 Analysis of Xist expression upon Oct4 deletion 4.2.1 
The data shown in the previous section raised the need to investigate whether the observed 
sharp upregulation of Xist in males is indeed associated with a weaker but nonetheless naïve 
identity or a consequence of naïve cell differentiation. To examine this, I first analysed Xist 
expression kinetics upon Oct4 deletion. Oct4 is considered a master regulator of pluripotency 
and its expression is required to sustain stem cell self-renewal (Niwa et al., 2000). Here, 
Oct4 deletion was achieved through the treatment of female and male Oct4flox/-, 
Rosa26CreERT2/+ ESCs with 4-OHT (Figure 4.1A). The gender of the ESC lines used for this 
experiment was confirmed by PCR (Figure 4.1B). Deletion of Oct4 was confirmed by both 
western blot and qRT-PCR (Figures 4.1C and 4.2A).  
Figure 4.1: Strategy for Oct4 conditional knockout.  
(A) Schematic of the strategy used to delete Oct4 from ESCs. Oct4flox/-, Rosa26CreERT2/+ were 
treated with 4-OHT which gave rise to Oct4-/- ESCs that were harvested at the indicated time 
points for analysis. These cell lines had been previously derived by Prof. Jennifer Nichols. 
(B) PCR-based sex determination of the Oct4flox/-, Rosa26CreERT2/+ ESC lines.  
(C) Western blot analysis of OCT4 in female and male Oct4flox/-, Rosa26CreERT2/+ ESCs in 2iL 
(0 hours) and at different time points following treatment with 4-OHT. 
These experiments were performed by Lawrence Bates and analysed by me. 
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In this context, the naïve network collapses as shown by a striking reduction in the 
expression of naïve markers (Figure 4.2A). Concomitantly with Oct4 deletion and exit from 
naïve pluripotency, both male and female cells exhibited a marked increase in the expression 
of Xist (Figure 4.2B). Strikingly, Xist expression in males reached 16% of the levels observed 
in female somatic cells (Figure 4.2B). 
These data, together with the results shown in section 3.2.3, link the loss of naïve 
gene expression and identity to the upregulation of Xist in male cells. 
Figure 4.2: Oct4 deletion leads to the collapse of the naïve network and Xist 
upregulation.  
(A and B) qRT-PCR analysis of (A) Oct4, other naïve markers (Nanog, Klf2, and Rex1) and 
(B) Xist in female and male Oct4flox/-, Rosa26CreERT2/+ ESCs in 2iL (0 hours) and at different 
time points following treatment with 4-OHT. Data shown are the mean of three technical 
replicates. Error bars represent ± SD. Female somatic cells (neural stem cells) were used as 
control for Xist expression. 
These experiments were performed by Lawrence Bates and analysed by me. 
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4.2.2  Xist is transiently and rapidly upregulated at the onset of male nPSC 
differentiation 
To study the kinetics of Xist expression during male differentiation, I induced differentiation of 
male ESCs that had been previously cultured in traditional SL or optimal 2iL (Figure 4.3). 
Importantly, three distinct differentiation conditions were employed. ESCs were differentiated 
in adherent monolayer in serum-free medium supplemented with FA or in serum-free 
medium only. Differentiation was also achieved by culture of ESCs in suspension in serum-
based medium without LIF. When cultured in these conditions, ESCs spontaneously 
differentiate and form three-dimensional multicellular aggregates called embryoid bodies 
(EBs)  (Doetschman et al., 1985). An EB contains cells that are committed for differentiation 
into all the three germ lineages and recapitulates many aspects of cell differentiation during 
early mammalian embryogenesis (Desbaillets et al., 2000; Itskovitz-Eldor et al., 2000). 
Surprisingly, a striking upregulation of Xist was observed in differentiating male 2iL 
ESCs (Figure 4.4A). Moreover, this was independent of the differentiation condition applied. 
Xist upregulation was transient and rapid, occurring between 1.5 and 2 days upon induction 
of differentiation (Figure 4.4A). Although less apparent, this pattern was also observed in 
differentiating male SL ESCs (Figure 4.4A). Importantly, analysis of a different male 2iL ESC 
line corroborated these findings (Figure 4.4B).  
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Figure 4.3: Strategy for differentiation of male nPSCs.  
Schematic illustrating three conditions employed to differentiate 2iL and SL ESCs: 
suspension culture in serum-based medium to generate EBs, adherent monolayer culture in 
serum-free medium supplemented with FA and adherent monolayer culture in serum-free 
medium only. 
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Figure 4.4: Xist is transiently upregulated during differentiation of ESCs.  
(A) qRT-PCR analysis of Xist during differentiation of male (XY1) ESCs in three different 
conditions. Before differentiation, ESCs were maintained in 2iL or SL conditions, as 
indicated.  
(B) qRT-PCR analysis of Xist during differentiation of male (XY2) ESCs in three different 
conditions. Before differentiation, cells were maintained in 2iL.  
(A and B) Data shown are the mean of three technical replicates. Error bars represent ± SD. 
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To test whether the same pattern could be observed during differentiation of induced 
pluripotent stem cells (iPSCs), I generated a male iPSC line that could be subsequently 
induced to differentiate. First, neural stem cells (NSCs) with a Rex1-dGFP reporter were 
derived from brains of E12.5 embryos and then one of the male NSC lines generated was 
reprogrammed into iPSCs (Figure 4.5A). Reprogramming of male Rex1-dGFP NSCs into 
iPSCs was successful as shown by acquisition of ESC-like morphology, activation of the 
Rex1-dGFP reporter (Figure 4.5B) and upregulation of naïve markers (Figure 4.5C). The 
iPSC line generated was then subjected to EB differentiation assay. Notably, Xist also 
underwent transient and rapid upregulation during differentiation of male iPSCs (Figure 
4.5D).  
I also induced a female ESC line to differentiate in order to compare the expression 
levels of Xist with those observed during differentiation of male ESCs. Remarkably, 1.5 days 
after induction of EB differentiation, Xist expression reaches very similar levels in male and 
female cells (Figure 4.6A). However, while Xist expression keeps increasing in differentiating 
female cells, in male cells it starts declining after 1.5 days of differentiation (Figure 4.6A). 
These results suggest that XCI may be initiated in both male and female cells upon induction 
of differentiation, but it is only maintained in female cells.  
Moreover, I found that differentiating female 2iL ESCs reach much higher Xist 
expression levels than female ESCs that were culture in SL before differentiation, even 
though Xist expression is lower at day 0 in 2iL conditions (Figure 4.6B). I hypothesise that 
this may be due to the transcriptional homogeneity of ESCs in 2iL which results in a more 
synchronous differentiation of these cells, although it could be due to other features such as 
signalling differences between 2iL and SL (Martello and Smith, 2014). I would like to reiterate 
that 2iL ESCs more closely represent in vivo naïve pluripotency in terms of their signalling, 
transcriptome and epigenetic profiles (Ahmed et al., 2010; Boroviak et al., 2014; Ficz et al., 
2013; Hackett et al., 2017; Smith et al., 2012). 
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Figure 4.5: Xist is transiently upregulated in differentiating iPSCs.  
(A) PCR-based sex determination of the Rex1-dGFP NSC lines derived. Cell line number 2 
was used to perform the subsequent experiments. Rex1-dGFP NSC lines were derived in 
collaboration with Hannah Stuart.  
(B) Phase and GFP images of the male iPSC line generated from NSCs. These cells express 
GFP indicating that reprogramming was successful.  
(C) qRT-PCR analysis of naïve markers (Rex1, Nanog, Oct4, Klf4, Klf2, and Esrrb) in Rex1-
dGFP NSCs before and after reprogramming to iPSCs (2iL-cultured). Rex1-dGFP ESCs in 
2iL were used as a control. 
(D) qRT-PCR analysis of Xist during EB differentiation of male iPSCs. Before differentiation, 
cells were maintained in 2iL.  
(C and D) Data shown are the mean of three technical replicates. Error bars represent ± SD. 
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Figure 4.6: At the onset of differentiation, Xist expression levels are similar in male 
and female cells.  
(A) qRT-PCR analysis of Xist during EB differentiation of male versus female 2iL ESCs.  
(B) qRT-PCR analysis of Xist during differentiation of female (XX1) ESCs in three different 
conditions. Before differentiation, ESCs were maintained in 2iL or SL conditions, as 
indicated.  
(A and B) Data shown are the mean of three technical replicates. Error bars represent ± SD.  
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To further validate the results showing that Xist is transiently upregulated during 
differentiation of male ESCs, differentiation time-courses were analysed by RNA-seq. It is 
important to highlight that the RNA-seq was strand-specific to ensure that Xist could be 
distinguished from its antisense transcript, Tsix. In agreement with the qRT-PCR data, when 
male 2iL ESCs are differentiated there is a surge of Xist expression that starts 1.5 days 
following induction of differentiation and lasts approximately 12 hours (Figure 4.7).  
Figure 4.7: Strand-specific RNA-seq shows increased expression of Xist in male 
differentiating cells.  
Strand-specific RNA-seq (negative strand only) showing the expression of Xist during 
differentiation of male (XY1) 2iL ESCs in three different conditions. Scale represents reads 
per million (RPM). The RNA-seq analysis was performed by Dr. Sabine Dietmann and Dr. 
Mohammadmersad Ghorbani. 
 
Principal component analysis (PCA) based on differentially expressed genes 
demonstrated that 2iL ESCs exhibit a more undifferentiated profile when compared to SL 
ESCs (Figure 4.8), which corroborates the qRT-PCR data from section 3.2.1 showing that 
transferring ESCs from SL to 2iL increases the expression of naïve pluripotency markers and 
is in agreement with previously published work (Martello and Smith, 2014). 
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Figure 4.8: nPSCs cultured in 2iL are more undifferentiated when compared to SL 
cells. 
PCA of differentiating male (XY1) cells based on differential expression of genes that had an 
expression of at least Log2 (normalized counts) 4.5 in at least one of the samples. Before 
differentiation, ESCs were maintained in 2iL or SL media, as indicated. Data was obtained by 
strand-specific RNA-seq. The RNA-seq analysis was performed by Dr. Sabine Dietmann and 
Dr. Mohammadmersad Ghorbani. 
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The expression of components of the Xic that have been directly or indirectly 
implicated in the regulation of Xist (Anguera et al., 2011; Barakat et al., 2011; Chureau et al., 
2011; Stavropoulos et al., 2001; Tian et al., 2010) was also analysed (Figure 4.9). 
Interestingly, Ftx and Jpx, which are putative positive regulators of Xist (Chureau et al., 2011; 
Tian et al., 2010), and Tsx, which is a putative positive regulator of Tsix (Anguera et al., 
2011), also appear to be downregulated by 2iL conditions in comparison to SL at day 0 
(Figure 4.9). This suggests that, like Xist, they might also be regulated by the naïve 
pluripotency network. Moreover, I observed that the non-coding RNA Ftx was upregulated 
during differentiation (Figures 4.9 and 4.10A) and may also contribute towards Xist 
upregulation. On the other hand, RNF12, which acts as an activator of Xist (Barakat et al., 
2011; Gontan et al., 2012), was transiently increased (Figure 4.10B) following an expression 
pattern similar to that of Xist in male differentiation. 
 
Global analysis of the expression pattern of long non-coding RNAs showed that Xist 
follows a pattern during differentiation that is distinct from all the other long non-coding RNAs 
(Figure 4.11). 
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Figure 4.9: Gene expression analysis of Xist regulators during differentiation of male 
nPSCs.  
Expression levels observed during differentiation of male (XY1) ESCs for Xist and other 
elements of the Xic that have been implicated in the regulation of Xist. Before differentiation, 
ESCs were maintained in 2iL or SL media, as indicated. Data were obtained by strand-
specific RNA-seq. Scale represents Log2 transformed expression value. The RNA-seq 
analysis was performed by Dr. Sabine Dietmann and Dr. Mohammadmersad Ghorbani.  
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Figure 4.10: Dynamics of Xist activators during differentiation of male nPSCs.  
(A) qRT-PCR analysis of Ftx during differentiation of male (XY1) ESCs in three different 
conditions. Before differentiation, cells were maintained in 2iL. Data shown are the mean of 
three technical replicates. Error bars represent ± SD.  
(B) Western blot analysis of RNF12 during differentiation of male (XY1) ESCs in FA. Before 
differentiation, cells were maintained in 2iL. 
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Figure 4.11: Gene expression analysis of long non-coding RNAs in differentiating male 
nPSCs.  
Figure legend continues on next page. 
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To position Xist modulation in the sequence of events taking place during 
differentiation, we analysed the timing of Xist upregulation relative to the expression of naïve 
pluripotency and lineage markers over time (Figure 4.12). Importantly, downregulation of 
naïve pluripotency factors, such as Nanog, Rex1, Esrrb, Klf2, Prdm14, and Tfcp2l1, 
preceded Xist upregulation. In contrast, expression of lineage markers was detected only 
after Xist upregulation. These results, together with the effect of naïve network perturbations 
on Xist expression shown in the previous chapter, indicate that the upregulation of Xist 
observed in male cells is a consequence of naïve cell differentiation and is caused by a 
weakening naïve pluripotency network. It also makes Xist a very early marker for male cells 
exiting naïve pluripotency. 
 
Altogether, these results demonstrate that male nPSCs also upregulate Xist upon 
induction of differentiation, an occurrence associated with initiation of XCI and previously 
ascribed exclusively to females. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11: Gene expression analysis of long non-coding RNAs in differentiating male 
nPSCs. 
Heatmap depicting the expression profile of long non-coding RNAs during differentiation of 
male (XY1) ESCs. Before differentiation, ESCs were maintained in 2iL or SL media, as 
indicated. Data was obtained by strand-specific RNA-seq. Scale represents z-scores of Log2 
transformed expression values. Xist is indicated with a red arrow. The RNA-seq analysis was 
performed by Dr. Sabine Dietmann and Dr. Mohammadmersad Ghorbani. 
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Figure 4.12: Gene expression analysis of differentiation and naïve markers during 
differentiation of male nPSCs.  
Heatmap showing the expression profile of Xist, differentiation and naïve markers during 
differentiation of male (XY1) 2iL ESCs, as indicated. Scale represents z-scores of Log2 
transformed expression values. The RNA-seq analysis was performed by Dr. Sabine 
Dietmann and Dr. Mohammadmersad Ghorbani. 
 
 Xist is transiently upregulated during reprogramming of male cells 4.2.3 
The aforementioned association between a strong naïve transcription factor network and the 
repression of Xist prompted us to investigate whether these are correlated in the context of 
reprogramming to naïve pluripotency in 2iL. We analysed the productive reprogramming 
intermediates from male EpiSCs (Figure 4.13A) using STAT3 activation (Yang et al., 2010) 
and Rex1-dGFP reporter activity (Kalkan et al., 2017) to induce and monitor reprogramming, 
respectively. STAT3 activation by phosphorylation was elicited by GCSF-stimulation of the 
GY118F receptor transgene (Yang et al., 2010) since LIF signal transduction of EpiSCs is 
limited (Burdon et al., 1999). I would like to note that obtained iPSCs were chimera and 
germline competent (Stuart et al., in preparation), demonstrating true establishment of naïve 
pluripotency.  
Flow cytometry analysis was performed at different time-points to collect the Rex1-
positive reprogramming intermediates for further analysis (Figure 4.13B). As expected, Xist 
was repressed in both male EpiSCs and control ESCs (Figure 4.13C). However, in 
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productive reprogramming intermediates, Xist was sharply upregulated (Figure 4.13C), prior 
to establishment of a consolidated nPSC identity.  
Overall, this suggests that Xist upregulation occurs in the presence of a weak naïve 
network, whether this be due to network collapse during differentiation initiation, or 
conversely due to the fragile nature of the nascent network during reprogramming.  
Figure 4.13: Xist is transiently upregulated during male EpiSC reprogramming.  
(A) PCR-based sex determination of the Rex1-dGFP EpiSC line.  
(B) Flow cytometry analysis of male GY118F Rex1+/GFP EpiSCs following reprogramming 
induction with GCSF in 2iL. Cells were sorted at different time points, with Rex1-dGFP 
reporter activation indicating the subset of cells successfully transitioning to the naïve 
identity. A representative plot from day 3 is shown. The reprogramming experiment was 
performed by Hannah Stuart.  
(C) qRT-PCR analysis of Xist and naïve markers (Oct4, Tfcp2l1, and Esrrb) in male GY118F 
Rex1-positive reprogramming intermediates at different time points after induction of 
reprogramming with 2iL+GCSF. Parental EpiSCs (day 0) and ESCs in 2iL were used as 
controls. Error bars represent ± SD. 
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 Discussion 4.3
In this chapter, I showed that Xist is upregulated rapidly and transiently during differentiation 
of male nPSC. Importantly, 1.5 days after differentiation induction, the levels of Xist 
expression are comparable between male and female cells, indicating that XCI appears to be 
initiated not only in female but also in male cells. 
These results suggest that gender-independent upregulation of Xist is linked to the 
downregulation of naïve pluripotency factors. I hypothesise that, in the context of a 
compromised naïve transcription factor network, known and putative positive regulators of 
Xist, such as RNF12 (Barakat et al., 2011; Gontan et al., 2012), Ftx (Chureau et al., 2011), 
and Jpx (Tian et al., 2010), may transiently gain the upper hand and induce Xist 
upregulation. However, Xist is subsequently rapidly suppressed suggesting that other 
mechanisms of Xist silencing are readily available. In agreement with this, deletion of Tsix, a 
known Xist repressor, has been previously correlated with the presence of an Xist cloud in a 
proportion of differentiating male nPSCs (Sado et al., 2002). Likewise, male Dnmt1 mutant 
nPSCs display Xist upregulation and consequent silencing of X-linked genes during 
differentiation (Beard et al., 1995; Panning and Jaenisch, 1996).  
It remained to be elucidated whether upregulation of Xist in differentiating male cells 
is accompanied by other events associated with XCI. I therefore address this in the 
subsequent chapter. 
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 Chapter 5 
Characterisation of X-chromosome silencing state during 
male and female naïve cell differentiation 
 
 Introduction 5.1
In Chapter 4, I showed that Xist is rapidly upregulated in a transient manner in early 
differentiating male cells upon collapse of the naïve pluripotent network. In female 
differentiating cells, once upregulated at the onset of XCI, Xist coats the entire future Xi in cis 
and induces several epigenetic changes, such as the accumulation of the repressive histone 
mark H3K27me3 (Plath et al., 2003; Silva et al., 2003). Ultimately, this results in silencing of 
one of the X-chromosomes. I demonstrated that, upon induction of differentiation, male cells 
appear to initiate XCI by upregulating Xist transiently. However, it remained to be elucidated 
whether this upregulation of Xist observed in males is accompanied by the same events that 
follow upregulation of Xist in female differentiating cells. 
It has been demonstrated that X-linked gene silencing is reversible during the first 3 
days of ESC differentiation (Wutz and Jaenisch, 2000). In the previous chapter, I observed 
that Xist upregulation takes place 1.5 days after induction of differentiation of male ESCs. 
Hence, I hypothesise that Xist upregulation might be inducing silencing of the male X-
chromosome given that the silencing state is fully reversible as long as Xist expression 
ceases within 3 days of differentiation.   
 
 Aims of the chapter 5.1.1 
In the previous chapter, I have demonstrated that male cells transiently and rapidly 
upregulate Xist at the onset of differentiation. In this chapter, I aimed to characterise Xist 
nuclear pattern during male and female naïve cell differentiation both in vitro and in vivo. 
Using early differentiating nPSCs, I also aimed to assess the silencing state of the single 
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male X-chromosome and of both female X-chromosomes, to ascertain the molecular impact 
of the observed Xist expression. 
 
 Results 5.2
 Male X-chromosome exhibits hallmarks of XCI upon upregulation of 5.2.1 
Xist 
In section 4.2.2, I showed that Xist is upregulated in a transient manner during differentiation 
of male nPSCs. Therefore, I wanted to examine whether the observed Xist upregulation in 
males was linked to events associated with the initiation of XCI as described for females. To 
determine this, I first assessed the nuclear pattern of Xist by RNA FISH. In differentiated 
female cells, Xist RNA coats the Xi in cis, forming a cloud-like structure that can be 
visualised by RNA FISH (Panning et al., 1997; Sheardown et al., 1997). Remarkably, 1.5 
days after male 2iL ESCs were induced to differentiate in FA, 20% of the cells showed Xist 
RNA expression (Figure 5.1A). Nearly half of the early differentiating male cells expressing 
Xist exhibited RNA clouds with a wide range of sizes (Figure 5.1A). Although in a smaller 
proportion, differentiating male SL ESCs also displayed expression of Xist (Figure 5.1B). I 
speculate that the percentage of cells expressing Xist in the latter case reflects the 
heterogeneity of the starting population which translates into greater cell differentiation 
asynchrony and consequently into fewer cells exhibiting Xist expression at a given snapshot. 
Unless stated otherwise, the subsequent differentiation experiments were performed in 2iL-
cultured ESCs. 
The expression of active CASPASE-3, which is an early marker of apoptosis, was 
evaluated to assess the viability of the Xist-positive male cells at 1.5 days of differentiation. 
Importantly, all analysed cells with Xist RNA upregulation were negative for active 
CASPASE-3. Moreover, only 1.4% of the cells were positive for this marker, a much lower 
percentage than that observed for the cells expressing Xist (Figure 5.2). Hence, I proceeded 
to the analysis of other XCI markers. 
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Figure 5.1: Differentiating male nPSCs display formation of Xist RNA cloud.  
(A and B) RNA FISH for Xist (red) in male (A) 2iL and (B) SL ESCs at 1.5 days of 
differentiation in FA using strand-specific probe. Nuclei are shown in blue (DAPI staining). 
White arrowheads indicate the location of the Xist signals. Quantification of the different Xist 
RNA patterns is shown. The ESC line used was E14tg2a (XY1). The scale bar represents 
5 μm. 
 
Figure 5.2: Male cells with Xist cloud do not express active CASPASE-3.  
Immuno RNA FISH for Xist (red) and cleaved CASPASE-3 (green) in male (XY1) 2iL ESCs 
at 1.5 days of differentiation in FA. Nuclei are shown in blue (DAPI staining). White 
arrowhead indicates the location of an Xist RNA cloud. The percentage of cleaved 
CASPASE-3-positive cells is indicated. None of the cells analysed were positive for both Xist 
and cleaved CASPASE-3. The scale bar represents 5 μm. 
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Accumulation of the repressive histone mark trimethyl-H3K27 (H3K27me3) on the 
inactivating X-chromosome is an event associated with XCI in female cells (Plath et al., 
2003; Silva et al., 2003). Interestingly, H3K27me3 accumulation on the X-chromosome was 
observed in 63% of male cells showing Xist RNA cloud (Figure 5.3A). I then addressed the 
status of acetyl-H3K27 (H3K27ac), which is a mark of active enhancers (Creyghton et al., 
2010). H3K27 hypoacetylation was found at the male Xist RNA cloud (Figure 5.3B). Negative 
control cells, in which the X-chromosome is marked by DNA FISH but there is lack of 
H3K27me3 and existence of H3K27ac, are also presented (Figures 5.3C and 5.3D). These 
results indicate that a silencing epigenetic signature has formed in the Xist-coated male X-
chromosome. 
 
 
 
 
67 
 
Figure 5.3: Differentiating male cells show accumulation of H3K27me3 and lack of 
H3K27ac.  
(A and B) Immuno RNA FISH for Xist (red) and (A) H3K27me3 or (B) H3K27ac (green) in 
male 2iL ESCs at 1.5 days of differentiation in FA. Nuclei are shown in blue (DAPI staining). 
White arrowheads indicate the location of the Xist cloud.  
(C) Immuno RNA FISH for Xist (red) and H3K27me3 (green) in male 2iL ESCs at 1.5 days of 
differentiation in FA with subsequent DNA FISH XY paint (greyscale). Nuclei are shown in 
blue (DAPI staining). Yellow arrowheads indicate the location of the X-chromosome. A cell 
lacking H3K27me3 on the X-chromosome is shown as a negative control. 
(D) Immunofluorescence for H3K27ac (green) in male 2iL ESCs at 1.5 days of differentiation 
in FA with subsequent DNA FISH XY paint (greyscale). Nuclei are shown in blue (DAPI 
staining). Yellow arrowheads indicate the location of the X-chromosome. A cell displaying 
H3K27ac on the X-chromosome is shown as a negative control.  
The ESC line used was E14tg2a (XY1). The scale bar represents 5 μm. 
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To examine whether Xist accumulation was inducing gene silencing, nascent 
transcripts of five X-linked genes – Rnf12, Nexmif, Nsdhl, Wbp5, and Huwe1 – were 
analysed by RNA FISH. The choice of X-linked genes was based on their distance to the Xist 
locus, on their expression levels in male early differentiating cells according to our RNA-seq 
data, and on whether they are silenced at an early or late stage as reported by Marks and 
colleagues (Marks et al., 2015). Huwe1 is quite distant from Xist (~48Mb), and the distance 
between the remaining genes and Xist ranges between 474kb and 33Mb. Furthermore, it has 
been reported that Huwe1 is silenced late during XCI, whilst silencing of the other selected 
genes occurs at an early stage (Marks et al., 2015). The percentage of cells expressing 
Rnf12, Nsdhl, and Nexmif was between 3- and 4-fold lower in male cells showing Xist cloud 
than in male cells lacking Xist accumulation (Figures 5.4A-C). In the case of Wbp5, no 
examples of gene expression were found at the male X-chromosome coated by Xist, while 
Wbp5 expression was detected in 9% of cells without Xist cloud (Figure 5.4C). In contrast, 
Huwe1 showed no difference between cells with or without Xist (Figures 5.4A and 5.4B). 
Moreover, for all X-linked genes analysed no differences were observed between cells with 
Xist pinpoint signal and cells with no Xist expression at all (Figures 5.4A and 5.4B). These 
data are consistent with a rapid transient upregulation of Xist in male cells, an upregulation 
that lasts long enough to have an impact on early silenced genes but not to affect late 
silenced ones. 
 
 
69 
 
Figure 5.4: Male cells undergo partial X-linked gene silencing during differentiation.  
(A) RNA FISH for Xist (red) and Rnf12, Nexmif or Huwe1 (greyscale) in male (XY1) 2iL ESCs 
at 1.5 days of differentiation in FA. Nuclei are shown in blue (DAPI staining). The scale bar 
represents 5 μm.  
(B) Quantification of the RNA FISH patterns for the X-linked genes Rnf12, Nexmif or Huwe1 
and Xist as shown in (A). Grey indicates the presence of Rnf12/Nexmif/Huwe1 signal and 
pink indicates the absence of Rnf12/Nexmif/Huwe1 signal.  
(C) Quantification of the RNA FISH patterns for the X-linked genes Nsdhl or Wbp5 and Xist 
in male 2iL ESCs at 1.5 days of differentiation in FA.  
Fisher’s exact test was used for statistical analyses. 
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Rnf12 and Nexmif, which were affected by Xist accumulation at the single cell level, 
were also analysed at the cell population level. Although there is some degree of Rnf12 
silencing at the single cell level, global levels of Rnf12 were not diminished during 
differentiation of male cells (Figure 5.5). Interestingly, Nexmif was transiently upregulated 
shortly before Xist during differentiation of both male and female cells (Figure 5.5). This may 
be indicative of a role in the regulation of Xist. As far as I am aware, Nexmif has not been 
associated with the process of XCI and it would be interesting to address this question in the 
future. 
 
Altogether, the results presented in this section show that several events associated 
with the process of XCI in female cells also take place during male differentiation. However, 
unlike female, male XCI is partial, transient and rapid. 
Figure 5.5: Cell population analysis of the genes affected by Xist coating of the male 
X-chromosome.  
qRT-PCR analysis of Rnf12, Nexmif, and Nanog during differentiation of female (XX1) and 
male (XY1) ESCs in FA. Before differentiation, cells were maintained in 2iL. Data shown are 
the mean of three technical replicates. Error bars represent ± SD. 
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 Female cells undergo transient biallelic Xist upregulation at the onset of 5.2.2 
differentiation 
It has been proposed that a mechanism of counting and choice precedes initiation of XCI in 
female cells (Monkhorst et al., 2008). The observed upregulation of Xist in male cells, which 
possess only one X-chromosome, questions the existence of this mechanism preceding 
initiation of XCI. To address this, I performed Xist RNA FISH in differentiating female nPSCs. 
In section 3.2.1, I showed that the female ESC line analysed here does not express Xist in 
self-renewing conditions. At 1.5 days of differentiation, I observed that 30% of the female 
cells expressing Xist display RNA accumulation on both X-chromosomes which can be 
visualized as two clouds (Figure 5.6A). Some of the cells also exhibited one Xist pinpoint 
signal and one cloud or two pinpoint signals (Figure 5.6A). Control experiments revealed that 
99% of the cells in this female ESC line have no more than two X-chromosomes (Figure 
5.6B) demonstrating that these results cannot be explained by the occurrence of tetraploid 
cells in culture.  
Figure 5.6: Female cells display two Xist clouds at the onset of differentiation.  
(A) RNA FISH for Xist (red) in female (XX1) 2iL ESCs at 1.5 days EpiSC differentiation in FA 
using strand-specific probe. Nuclei are shown in blue (DAPI staining). Quantification of the 
different Xist RNA patterns is shown.  
(B) RNA FISH in female (XX1) 2iL ESCs with a strand-specific probe detecting X-encoded 
nascent RNA of Huwe1 (greyscale). Nuclei are shown in blue (DAPI staining). Quantification 
of the different RNA FISH patterns is shown.  
The scale bar represents 5 μm. 
 
To assess whether Xist accumulation is inducing gene silencing on both X-
chromosomes, I carried out RNA FISH analysis of Rnf12 and Huwe1 nascent transcripts in 
female cells after 1.5 days of differentiation (Figures 5.7A and 5.7B). The incidence of 
biallelic silencing of Rnf12 was 12-fold greater in female cells exhibiting Xist RNA 
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accumulation on both X-chromosomes than in cells not expressing Xist (Figure 5.7B). On the 
other hand, Huwe1 showed no difference between the two groups (Figure 5.7B). These 
results are in agreement with the data shown for male cells in which all X-linked genes 
analysed except Huwe1 show some degree of silencing. 
 
These results suggest that the choice of which X-chromosome is going to be 
irreversibly silenced may follow rather than precede the initiation of XCI. 
Figure 5.7: Female cells undergo transient biallelic silencing of X-linked genes during 
differentiation.  
(A) RNA FISH for Xist (red) and Rnf12 or Huwe1 (greyscale) in female (XX1) 2iL ESCs at 1.5 
days of differentiation in FA. Nuclei are shown in blue (DAPI staining). The scale bar 
represents 5 μm.  
(B) Quantification of the RNA FISH patterns for the X-linked genes Rnf12 or Huwe1 and Xist 
as shown in (A). Dark grey indicates biallelic Rnf12/Huwe1 signal, light grey indicates 
monoallelic Rnf12/Huwe1 signal and pink indicates absence of Rnf12/Huwe1 signal. 
 
 Transient Xist upregulation occurs as nPSCs become NANOG-negative 5.2.3 
To investigate whether Xist upregulation corresponds with a particular differentiation stage, I 
analysed the expression of NANOG and OCT4 relative to Xist at the single cell level in both 
male and female differentiating cells (Figures 5.8 and 5.9). First, expression profile of 
NANOG and OCT4 was determined in the bulk population of cells independent of the Xist 
status. In both male and female, most cells remained OCT4-high whereas NANOG 
expression was variable at 1.5 days of differentiation (Figures 5.8A-B and 5.9A-B). I 
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hypothesise that this variability was due to asynchronicity in nPSC differentiation, as 
previously reported in Kalkan and et al., 2017. Expression of NANOG and OCT4 was then 
analysed focusing only on Xist-expressing male differentiating cells. Interestingly, Xist 
upregulation occurred exclusively in male cells that were either NANOG-low or NANOG-
negative (Figures 5.8A and 5.8C). Moreover, most Xist-expressing male cells were OCT4-
high (Figures 5.8A and 5.8C). Expression profiles of NANOG and OCT4 were also examined 
specifically in differentiating female cells with biallelic expression of Xist. Likewise, biallelic 
Xist upregulation was mainly found in female cells that were OCT4-high and NANOG-low or 
NANOG-negative (Figures 5.9A and 5.9C).  
 
These results indicate that transient Xist upregulation occurs in a defined 
developmental window and in close relationship with a weakening naïve network.  
 
Figure 5.8: Analysis of the expression of NANOG and OCT4 relative to Xist at the 
single cell level in male differentiating cells.  
(A) Immuno RNA FISH for Xist (red), NANOG (green), and OCT4 (greyscale) in male (XY1) 
2iL ESCs at 1.5 days of differentiation in FA. Nuclei are shown in blue (DAPI staining). White 
arrowheads indicate the location of the Xist clouds.  
(B and C) Quantification of the NANOG and OCT4 expression profile in (B) the bulk 
population and in (C) cells with Xist cloud as shown in (A). 
The scale bar represents 5 μm. 
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Figure 5.9: Analysis of the expression of NANOG and OCT4 relative to Xist at the 
single cell level in female differentiating cells.  
(A) Immuno RNA FISH for Xist (red), NANOG (green) and OCT4 (greyscale) in female (XX1) 
2iL ESCs at 1.5 days of differentiation in FA. Nuclei are shown in blue (DAPI staining). White 
arrowhead indicates the location of a cell with biallelic Xist upregulation.  
(B and C) Quantification of NANOG and OCT4 expression profile in (B) the bulk population 
and in (C) cells with biallelic Xist expression as shown in (A). 
The scale bar represents 5 μm. 
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 Xist is transiently upregulated monoallelically in males and biallelically 5.2.4 
in females during embryo implantation 
The E4.5 naïve epiblast is molecularly and functionally very similar to in vitro 2iL nPSCs 
(Boroviak et al., 2015; Nichols and Smith, 2009). Given the observed transient upregulation 
of Xist during in vitro male nPSC differentiation, I investigated whether this phenomenon also 
takes place during in vivo differentiation of the naïve pluripotent epiblast. Male and female 
embryos could be readily distinguished based on Xist expression patterns as cells of 
extraembryonic tissues in female embryos, but not male, would display an Xist RNA cloud at 
all developmental stages examined. Sex was confirmed for a number of embryos by PCR 
analysis (Figure 5.10A). I started by performing Xist RNA FISH on E4.5 embryos to assess 
whether they present the same Xist expression pattern as their in vitro counterpart nPSCs as 
shown in section 3.2.1. I observed that E4.5 naïve epiblast cells do not display Xist 
expression in either sex (Figure 5.10B) which is in agreement with the findings in nPSCs. 
From E4.5, the embryo starts implanting and naïve pluripotent gene expression is rapidly 
downregulated (Boroviak et al., 2015). Thus, E5.5 male and female post-implantation 
embryos were analysed in an attempt to find a match between this developmental stage and 
the differentiation time point analysed in vitro – 1.5 days. At E5.5, I also failed to detect Xist 
expression in males whereas female epiblasts already exhibited one Xist cloud in nearly all 
cells (Figure 5.10B), meaning that XCI had already been completed. This prompted me to 
examine earlier time points. Remarkably, at E4.75-5.0, I found 1 to 3 cells per male epiblast 
exhibiting Xist upregulation (Figure 5.11A and 5.11B). When analysing female epiblast cells 
for the same time points, I observed that Xist was biallelically upregulated in up to 10% of the 
epiblast cells showing expression of Xist (Figures 5.11A-C). Together, these data indicate 
that at implantation stage, male and female epiblast cells undergo transient and rapid 
monoallelic and biallelic upregulation of Xist, respectively, and this correlates with the 
downregulation of the naïve epiblast network. 
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Figure 5.10: Xist is not expressed at E4.5 in vivo.  
(A) PCR-based sex determination of mouse embryos used in this study.  
(B) RNA FISH for Xist in representative male and female epiblasts of mouse embryos at E4.5 
and E5.5. The scale bar represents 10 μm.  
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Figure 5.11: Xist is transiently upregulated monoallelically in males and biallelically in 
females in vivo.  
Figure legend continues on the next page.  
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Figure 5.11: Xist is transiently upregulated monoallelically in males and biallelically in 
females in vivo.  
(A) RNA FISH for Xist in representative male and female epiblasts of mouse embryos at 
E4.75-5.0. Examples of cells with monoallelic Xist expression in males and biallelic 
expression in females are delineated with yellow dashed lines. The scale bar represents 
10 μm.  
(B) Higher magnifications of the cells delineated with yellow dashed lines in (A) are shown. 
(C) Graphical representation of the percentage of cells with biallelic Xist over the total 
number of epiblast cells expressing Xist analysed in female embryos at indicated 
developmental stages. 
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 Discussion 5.3
In this chapter, I demonstrated that Xist accumulates transiently on the male X-chromosome 
and induces partial X-linked transcriptional silencing in early differentiating cells. Additionally, 
I observed transient biallelic accumulation of Xist and partial biallelic X-linked gene silencing 
in female differentiating cells. I would like to note that the percentages reported here are only 
representative of a snapshot in time. Due to the asynchronous nature of differentiation and 
transience of the events described in this study, I hypothesise that the fraction of cells 
displaying monoallelic Xist upregulation in males or biallelic in females at 1.5 days of 
differentiation may underrepresent the actual percentage of cells undergoing this 
phenomenon throughout differentiation. It would be interesting to investigate this further by 
developing an Xist reporter system for male and female nPSCs in order to monitor Xist 
expression at the single cell level during differentiation. 
It has been previously shown that male E4.5 naïve epiblast cells exhibit one pinpoint 
Xist signal, whereas two Xist pinpoint signals could be detected in the majority of female 
E4.5 naïve epiblast cells (Sheardown et al., 1997). Conversely, I demonstrated that Xist is 
not expressed in E4.5 naïve epiblast cells in either sex. These differences might be 
explained by the fact that, in previous studies, FISH probes were not strand-specific and thus 
would also detect the expression of Xist antisense RNA, Tsix. Here, the embryos were 
analysed using a strand-specific probe that only detects the expression of Xist. Having 
established that Xist is not expressed in pre-implantation male naïve epiblast cells, allowed 
the detection of an upregulation of Xist in a small percentage of male epiblast cells shortly 
after implantation. Similarly, Xist was expressed biallelically in approximately 10% of Xist 
expressing female epiblast cells at E4.75-E5.0. Interestingly, this is the time point in vivo 
when the naïve network is downregulated (Boroviak et al., 2015). As for the nPSCs, the 
asynchrony of cell differentiation and the transiency of this event need to be taken into 
consideration. 
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 Chapter 6 
General discussion 
 
 Parallels to human XCI 6.1
It is well established that female mice undergo X-chromosome dosage compensation 
via XCI in two waves. At 4- to 8-cell stage, female mouse embryos initiate the first wave of 
XCI (Okamoto et al., 2004). This results in silencing of the X-chromosome of paternal origin 
in all cells of the early embryo in a process known as imprinted XCI (Takagi and Sasaki, 
1975; West et al., 1977). The paternal X-chromosome is transiently reactivated in cells of the 
naïve pluripotent epiblast at E4.5 (Mak et al., 2004; Okamoto et al., 2004; Silva et al., 2009; 
Williams et al., 2011), and around 24 hours later a second wave of random XCI takes place 
(Okamoto et al., 2005).  
Similarly to the mouse, random XCI also occurs after human embryo implantation, 
leading to inactivation of either the paternal or the maternal X-chromosome. However, in 
contrast to the mouse, recent reports demonstrated that imprinted XCI does not take place in 
human pre-implantation embryos (Moreira de Mello et al., 2010; Okamoto et al., 2011; 
Petropoulos et al., 2016). According to Petropoulos and colleagues, dosage compensation in 
human pre-implantation embryos is achieved not by inactivation of one of the two X-
chromosomes in the female, but rather by reducing X-linked gene expression of both female 
X-chromosomes (Petropoulos et al., 2016). This X-chromosome dampening (XCD) is thought 
to be mediated by the long non-coding XIST which is transcribed from both alleles 
throughout this process (Okamoto et al., 2011; Petropoulos et al., 2016; Vallot et al., 2017). 
Moreover, expression of XIST, which starts at the 4-8-cell state of the human embryo, 
increases over time up to E7.0 and correlates with X-linked dampening (Petropoulos et al., 
2016). Interestingly, an expression imbalance between the X-chromosomes was detected 
from E6.0, suggesting that X-linked gene silencing may initiate in a progressive manner at 
this developmental stage (Vallot et al., 2017). However, these experiments were performed 
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with embryos cultured in vitro and potential differences with their in vivo counterparts cannot 
be excluded, meaning that caution should be used when interpreting these results. 
Accumulation of XIST on the single X-chromosome was also observed in human 
male embryos, even though the proportion of XIST-expressing cells was discrepant between 
studies (Okamoto et al., 2011; Petropoulos et al., 2016; Vallot et al., 2017). I hypothesise that 
accumulation of XIST on the single X-chromosome in human male embryos and on both X-
chromosomes in human female embryos might be akin to what I am reporting in this 
dissertation for the mouse. It remains to be elucidated whether this phenomenon observed in 
the human is associated with the naïve transcription factor network. 
 
 Progress in understanding XCI 6.2
According to the prevailing paradigm, Xist is expressed at low levels in both female and male 
mouse nPSCs (Panning et al., 1997; Sheardown et al., 1997). However, most of the studies 
investigating XCI have been performed using ESCs cultured in SL, which are known to be 
suboptimal (Chambers et al., 2007; Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 2013; 
Marks et al., 2012; Martello and Smith, 2014). Using conditions that enable the culture of 
mouse nPSCs that closely resemble the naïve pluripotent epiblast both transcriptionally and 
epigenetically (Boroviak et al., 2014; Ficz et al., 2013; Habibi et al., 2013; Hackett et al., 
2017; Leitch et al., 2013), I demonstrated that Xist is indeed not expressed in these cells 
(Chapter 3). As shown in this study and in previous publications (Martello and Smith, 2014), 
2iL culture conditions increase the strength of the naïve pluripotent network by augmenting 
the expression of its members. I observed that, in the presence of a robust naïve network, 
the expression of Xist is repressed (Chapter 3). Importantly, these results were corroborated 
by Xist RNA FISH analysis of male and female E4.5 embryos (Chapter 5). Similarly to 
nPSCs, Xist is not expressed in the naïve epiblast of E4.5 embryos, the starting identity from 
which random XCI occurs (Chapter 5).  
It has been proposed that random XCI has five key phases in the following order: 
counting, choice, initiation, establishment, and maintenance (Avner and Heard, 2001; Boumil 
and Lee, 2001; Lyon, 1999). The first step in the process of XCI consists of a recognition 
step in which the number of X-chromosomes in the cell is counted relative to the number of 
autosomes in order to ensure that only a single X-chromosome is active per diploid genome, 
i.e. that XCI occurs for females but not males (Grumbach et al., 1963; Lyon, 1962). A 
process of choice then occurs, whereby one of the two X-chromosomes in the female cell is 
selected for inactivation (Cattanach and Williams, 1972). According to the current paradigm, 
initiation of XCI occurs after these two phases have taken place and coincides with the 
upregulation of Xist from the future Xi (Brown et al., 1991). Here, I showed that Xist 
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accumulates transiently on the single male X-chromosome and on both female X-
chromosomes at the onset of naïve cell differentiation (Chapter 4). These findings suggest 
that the phases of counting and choice are not required for XCI initiation. Moreover, our 
results indicate that downregulation of the naïve transcription factor network acts as the main 
trigger for the initiation of XCI regardless of the gender (Figure 6.1). 
Therefore, I propose that counting and choice only take place after gender-
independent initiation of XCI. This represents a paradigm-shift in our understanding of the 
XCI process. 
I also showed that accumulation of Xist on the male X-chromosome triggers the 
enrichment of repressive epigenetic marks leading to partial X-linked gene silencing (Chapter 
5). Importantly, I observed that these steps take place within a defined window of time where 
the process of XCI is known to be reversible (Wutz and Jaenisch, 2000), meaning that as 
long as Xist expression ceases within 3 days of differentiation any induced changes on the 
X-chromosome are fully reversible. Indeed, our data show that Xist expression is already 
downregulated by day 3 of differentiation of male nPSCs. Therefore, I hypothesise that in the 
mouse species a counting mechanism occurs only after XCI initiation, but still during the 
reversible period. 
Previous studies suggested that initiation of XCI in females is preceded by pairing of 
the two Xic loci and that the process of choice was dependent on pairing, thereby restricting 
XCI to female cells (Bacher et al., 2006; Xu et al., 2006). Our data indicate that pairing of the 
two Xic and choice occur after initiation of XCI. However, I speculate that the requirement of 
two Xic for the process of pairing and choice to occur might still be one of the mechanisms 
ensuring that irreversible XCI takes place in female cells only. Moreover, although the 
negative regulation of Xist by the naïve transcription factor network is the same in male and 
female cells, all known Xist activators are located on the X-chromosome, meaning that they 
will be duplicated in females relative to males (Chureau et al., 2011; Jonkers et al., 2009; 
Tian et al., 2010). This will ensure that only female cells can overcome the threshold for 
permanent XCI to occur. It could be interesting to further understand how these and other 
mechanisms allow XCI to be maintained in females only. 
In conclusion, our study re-defines the paradigm of XCI and opens up new avenues 
to investigate how this process is regulated. 
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Figure 6.1: The link between naïve pluripotency and XCI.  
Schematic representation of the main findings of this thesis. In both male and female nPSCs 
with a robust naïve transcription factor network, Xist is not expressed. At the onset of 
differentiation, and as the naïve network weakens, Xist transiently coats the single X-
chromosome in males and both X-chromosomes in females. When these cells are fully 
differentiated, Xist expression is extinguished in males and there is coating of only one of the 
two X-chromosomes in females. 
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A hallmark of naive pluripotency is the presence of
two active X chromosomes in females. It is not clear
whether prevention of X chromosome inactivation
(XCI) is mediated by gene networks that preserve
the naive state. Here, we show that robust naive
pluripotent stem cell (nPSC) self-renewal represses
expression of Xist, the master regulator of XCI. We
found that nPSCs accumulate Xist on the male X
chromosome and on both female X chromosomes
as they become NANOG negative at the onset of dif-
ferentiation. This is accompanied by the appearance
of a repressive chromatin signature and partial
X-linked gene silencing, suggesting a transient and
rapid XCI-like state in male nPSCs. In the embryo,
Xist is transiently expressed in males and in females
from both X chromosomes at the onset of naive
epiblast differentiation. In conclusion, we propose
that XCI initiation is gender independent and trig-
gered by destabilization of naive identity, suggesting
that gender-specific mechanisms follow, rather than
precede, XCI initiation.
INTRODUCTION
In order to achieve dosage compensation, female mammals
have one inactive X chromosome (Xi). However, in female murine
embryos, the Xi is reactivated in the pre-implantation blastocyst
(Mak et al., 2004; Okamoto et al., 2004) specifically in the cells of
the naive pluripotent epiblast (Silva et al., 2009). Their in vitro
counterpart, naive pluripotent stem cells (nPSCs), retain this em-
bryonic feature, making them an excellent model system to
study X chromosome inactivation (XCI). XCI is initiated upon dif-
ferentiation of female nPSCs and is characterized by monoallelic
upregulation of Xist, the non-coding RNA which coats the future
Xi in cis (Panning et al., 1997; Sheardown et al., 1997). In
contrast, Xist expression is extinguished during differentiation
of male nPSCs.Cell Stem Cell 22, 919–928, Ju
This is an open access article undThe link between a naive pluripotent cellular identity and the
lack of a Xi in females is still poorly understood. In the pre-im-
plantation blastocyst, reactivation of the Xi occurs in cells ex-
pressing the nPSCmarker NANOG (Silva et al., 2009). Moreover,
NANOG and other members of the naive transcriptional network
were found to bind to Xist intron 1 (Navarro et al., 2008). Deletion
of Nanog and Oct4 was shown to induce a moderate upregula-
tion of Xist (Navarro et al., 2008), but deletion of Xist intron 1
was shown to be dispensable for XCI and did not affect Xist
expression (Minkovsky et al., 2013).
X chromosome reactivation (XCR) is also a feature during
in vitro nuclear reprogramming to naive pluripotent cell identity
(Tada et al., 2001). The general consensus is that naive pluripo-
tent gene regulators must play a role both in vivo and in vitro XCR
(Navarro et al., 2008, 2010, 2011; Pasque and Plath, 2015; Pas-
que et al., 2014; Payer et al., 2013; Silva et al., 2009).
Studies investigating the process of XCI have largely been
conducted in vitro and using nPSCs cultured in serum/LIF
(SL) conditions. This is known to be suboptimal, as it induces
transcriptional heterogeneity of pluripotency factors (Chambers
et al., 2007), promotes an overall weak naive transcription fac-
tor (TF) network in which spontaneous differentiation and
increased expression of lineage markers are observed (Marks
et al., 2012), and exhibits epigenetic constraints (Ficz et al.,
2013; Habibi et al., 2013; Leitch et al., 2013; Marks et al.,
2012). It is also known to reduce reprogramming efficiency
(Silva et al., 2008) and to decrease the ability of nPSCs to enter
embryonic development (Alexandrova et al., 2016). Using
defined serum-free medium containing LIF and inhibitors of
mitogen-activated protein kinase signaling and glycogen syn-
thase kinase-3b (2iL), these limitations have been overcome
(Silva et al., 2008; Silva et al., 2009; Ying et al., 2008). 2iL
acts on the TF network governing the naive identity by boosting
its expression (Martello and Smith, 2014). In addition, nPSCs
cultured in 2iL exhibit a transcriptional signature that is similar
to the naive pluripotent epiblast (Boroviak et al., 2015). How-
ever, it is unknown whether increased transcriptional homoge-
neity and pluripotent TF robustness have an impact on the
process of XCI.
Here, we assessed the relationship between naive pluripotent
cell identity and the process of XCI. This uncovered unexpected
XCI events during differentiation of bothmale and female nPSCs.ne 1, 2018 Crown Copyright ª 2018 Published by Elsevier Inc. 919
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Xist Expression Is Abolished by a Robust Naive Pluripotent Network
(A) Schematic illustrating the experiment performed to evaluate the impact of the nPSC culture conditions on the expression of Xist.
(B) qRT-PCR analysis of Nanog and Xist in XX1, XX2, XY1, and XY2 ESC lines in SL versus 2iL. P indicates number of passages in 2iL. Error bars represent ± SD.
(C) Flow cytometry analysis of male SL Nanog-GFP ESCs and subsequent sorting into three Nanog-GFP populations: low, medium, and high.
(D) qRT-PCR analysis of Nanog, Klf4, Oct4, and Xist in low, medium, and high Nanog-GFP ESCs. Error bars represent ± SD.
(E) Strand-specific RNA-seq showing expression of the positive and negative strands at theXist locus inmale 2iL ESCs. The double-strandXist probe used in (F) is
represented in red.
(legend continued on next page)
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These observations impact our understanding of XCI and its rela-
tionship with the naive pluripotent identity.
RESULTS
Robust nPSC Self-Renewal Abolishes Xist Expression
To evaluate the impact of gene expression homogeneity and
increased naive pluripotent gene expression on the levels of
Xist, we analyzed two male and two female SL-derived embry-
onic stem cell (ESC) lines before and after passaging in 2iL (Fig-
ures 1A, S1A, and S1B). As expected, upregulation of naive
pluripotent network components was observed after transferring
cells from SL to 2iL (Figures 1B and S1C). Remarkably, 2iL con-
ditions led to repression of Xist in both male and female ESCs
after only one passage (Figure 1B).
ESCs in SL present heterogeneous levels of naive markers
(Chambers et al., 2007), rendering these cells a useful tool
to study the relationship between naive network status and
Xist expression. Male SL ESCs with Nanog-GFP reporter
were sorted into low, medium, and high GFP populations (Fig-
ures 1C and S1D). Oct4 levels were maintained in all three frac-
tions, whereas the pluripotency factor Klf4 positively correlated
with Nanog expression (Figure 1D). Interestingly, Xist expres-
sion was 28-fold lower in Nanog-high than Nanog-low cells
(Figure 1D).
To validate the qRT-PCR data, we performed strand-specific
RNA sequencing (RNA-seq) in 2iL-cultured male nPSCs. This
clearly showed that expression at the Xist locus was exclusively
antisense (Figure 1E). We also analyzed the pattern of Xist by
RNA fluorescence in situ hybridization (FISH) using a single-
strand (ss) Xist-specific probe and a conventional double-strand
(ds) probe detecting Xist exon 1 and also any present antisense
transcript. When using the ds probe and depending on the
gender, one or two pinpoints were detected in 88% or 97% of
cells, respectively (Figure 1F). In contrast, with the ss probe,
Xist was detected in less than 2% of cells (Figure 1F). Together,
these data demonstrate that Xist is not expressed in robust self-
renewing nPSCs.
2iL culture medium allows the removal of otherwise essential
components of the naive TF network (Ying et al., 2008). Thus,
we assessed the effect of the withdrawal of these on Xist expres-
sion over 3 days. We performed 4-hydroxytamoxifen (4-OHT)-
mediated Cre deletion of Nanog from Nanogflox/, Rosa26-
CreERT2 ESCs (Figures 1G and S1F–S1H). We found an inverse
correlation between the expression of Nanog and Xist, which
was highly upregulated in both females and males (Figure 1G).
As expected, Nanog deletion also had an effect on the expres-
sion of its downstream targets such as Klf4 and Esrrb, but not
on Oct4 or other naive pluripotency genes (Figure S1H).
JAK/STAT3 signaling plays an important role in the mainte-
nance of pluripotency (Martello and Smith, 2014). In addition,(F) RNA FISH inmale and female 2iL ESCswith a double-strand (ds) probe (left) or w
with probe signal is indicated. Female EpiSCs were used as a control for the ss
(G) qRT-PCR analysis of Nanog and Xist in female and male Nanogflox/, Rosa26-
Error bars represent ± SD.
(H) qRT-PCR analysis of Xist in XX3 and XY1 ESCs in 2iL, 2i or after 3 and 5 day
(I) qRT-PCR analysis ofOct4 and Xist in female andmaleOct4flox/, Rosa26-CreER
somatic cells were used as control for Xist expression. Error bars represent ± SDactivated STAT3 (p-STAT3) and its downstream target genes
have binding sites within the X-inactivation center (XIC) that har-
bors Xist and other genes involved in its regulation (Sa´nchez-
Castillo et al., 2015). Here, inhibition of JAK/STAT3 signaling
was achieved by treatment of ESCs with a JAK inhibitor (JAKi)
and confirmed by depletion of p-STAT3 (Figures 1H, S1I, and
S1J) and downregulation of its target Socs3 (Figure S1K). Inter-
estingly, treatment with 1 mM JAKi induced upregulation of Xist
in both female and male ESC lines (Figure 1H).
Overall, these data show that perturbing the naive pluripotent
network leads to a sharp upregulation of Xist in both male and
female ESCs. However, inhibition of JAK/STAT3 signaling also
impacted expression of naive factors, such asOct4 (Figure S1K),
which are known to be required for the integrity of the pluripo-
tency network. This raised the need to investigate whether the
observed sharp upregulation of Xist in males is indeed associ-
ated with a weaker but nonetheless naive identity or/and a
consequence of naive cell differentiation. To investigate this,
we analyzed Xist expression kinetics upon 4-OHT-mediated
Cre deletion of Oct4 in male and female Oct4flox/, Rosa26-
CreERT2 ESCs (Figures 1I, S1L, S1M, and S1N). In this context,
the naive network collapses and cells lose the naive identity.
Importantly, concomitantly with Oct4 deletion, both female and
male cells exhibited a striking increase in the expression of Xist
(Figure 1I). In males, this reached 16% of Xist female somatic
cell levels.
Together, these data link the loss of naive gene expression and
identity to the upregulation of Xist.
Xist Is Highly Expressed in a Transient and Rapid
Fashion at the Onset of Male nPSC Differentiation
It is defined in the literature that Xist is repressed as male
nPSCs undergo differentiation both in vivo and in vitro (Panning
et al., 1997; Sheardown et al., 1997). Intriguingly, our results
above showed a surprisingly high upregulation of Xist in
males with a compromised naive network, leading us to
revisit the kinetics of Xist expression during male nPSC differ-
entiation. To address this, we induced differentiation of male
ESCs that had previously been cultured in either traditional
SL or optimal 2iL (Figure 2A). Surprisingly, a striking upregula-
tion of Xist was observed in differentiating male 2iL ESCs
(Figure 2B). Moreover, this was independent of the differentia-
tion condition applied. Xist upregulation was transient and
rapid, occurring between 1.5 and 2 days after induction of dif-
ferentiation (Figure 2B). Although less apparent, this pattern
was also observed in differentiating male SL ESCs (Figure 2B).
These results were confirmed using independent male ESC
and induced pluripotent stem cell (iPSC) lines (Figures S2A
and S2B).
Recent reports highlighted that erosion of imprints can occur
during the culture of nPSCs (Choi et al., 2017; Yagi et al.,ith a single-strand (ss) probe detecting only Xist (right). The percentage of cells
probe. The scale bar represents 5 mm.
CreERT2 ESCs in 2iL at indicated time points following treatment with 4-OHT.
s in 1 mM JAKi + 2i. Error bars represent ± SD.
T2 ESCs in 2iL at indicated time points following treatment with 4-OHT. Female
.
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Figure 2. Xist Is Transiently and Rapidly Upregulated in Male nPSC Differentiation and Male EpiSC Reprogramming
(A) Schematic illustrating three conditions employed to differentiate 2iL and SL nPSCs: suspension culture in serum to generate EBs or adherent monolayer
culture in serum-free media ± Fgf2+ActivinA (FA).
(B) qRT-PCR analysis of Xist during differentiation of male ESCs in three different conditions. Before differentiation, ESCswere maintained in 2iL or SL conditions,
as indicated. Error bars represent ± SD.
(C) Strand-specific RNA-seq (negative strand only) showing expression of Xist during differentiation of male 2iL ESCs in three different conditions. Scale rep-
resents reads per million (RPM).
(D) Heatmap showing expression profile of Xist, differentiation markers, and naive markers during differentiation of male 2iL ESCs, as indicated. Scale represents
Z scores of log2-transformed expression values.
(E) qRT-PCR analysis of Xist during EB differentiation of male versus female 2iL ESCs. Error bars represent ± SD.
(F) Flow cytometry analysis of male GY118F Rex1+/dGFP EpiSCs following reprogramming induction with GCSF in 2iL. Cells were sorted at different time points,
with Rex1-dGFP reporter activation indicating the subset of cells successfully transitioning to the naive identity. A representative plot from day 3 is shown.
(G) qRT-PCR analysis of Xist and naive markers (Oct4, Tfcp2l1, and Esrrb) in male Rex1-positive reprogramming intermediates at different time points after
induction of reprogramming with 2iL+GCSF/GY118F. Parental EpiSCs (day 0) and ESCs in 2iL were used as controls. Error bars represent ± SD.
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(legend continued on next page)
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2017). However, Xist is unlikely to have its expression pattern
affected, as it is not an imprinted gene in either the naive epiblast
or nPSCs.
Independent differentiation time courses were analyzed by
strand-specific RNA-seq. In agreement with the qRT-PCR
data, when male 2iL ESCs are differentiated, there is a surge of
Xist expression that starts 1.5 days following induction of differ-
entiation and lasts approximately 12 hr (Figure 2C). Principal-
component analysis (PCA) based on differentially expressed
genes showed that 2iL ESCs have a more undifferentiated start-
ing point in relation to SL ESCs (Figure S2C), which corroborates
our qRT-PCR data showing that transferring nPSCs from SL to
2iL increases the expression of naive pluripotency markers.
The expression of known regulators of Xist was also analyzed.
Ftx, Jpx, and Tsx also appear to be downregulated by 2iL condi-
tions in comparison to SL at day 0 (Figure S2D). Upon differenti-
ation, positive and negative regulators of Xist are also transiently
upregulated (Figures S2D–S2F). Global analysis of the expres-
sion pattern of long non-coding RNAs showed that Xist follows
a pattern during differentiation that is distinct from other long
non-coding RNAs (Figure S3A).
To position Xist upregulation in the sequence of events taking
place during differentiation, we compared its timing relative to
naive pluripotent and lineage marker gene expression (Fig-
ure 2D). Importantly, downregulation of the naive pluripotency
factors Sox2, Nanog, Rex1, Esrrb, Klf2, Prdm14, and Tfcp2l1
preceded Xist upregulation. In contrast, expression of lineage
markers was detected only after Xist upregulation. In combina-
tion with the effects of naive network perturbations on Xist
expression (Figure 1), these results indicate that the upregulation
of Xist observed in male cells upon induction of differentiation is
caused by a weakening naive pluripotent network.
The differentiation experiments were also performed in a fe-
male ESC line. Remarkably, 1.5 days after induction of embryoid
body (EB) differentiation, Xist expression reaches very similar
levels in male and female cells (Figure 2E). However, while Xist
expression keeps increasing in female cells, it starts declining
in male cells.
Together, these results reveal that at the onset of differentia-
tion, males upregulate Xist at a level similar to that of females.
Xist Is Transiently Upregulated during Reprogramming
of Male Cells
The aforementioned mechanistic association between a func-
tional naive TF network and the repression of Xist led us to
investigate whether these are correlated in the context of reprog-
ramming to naive pluripotency in 2iL.We analyzed the productive(B) Immuno-RNA FISH for Xist (red) and H3K27me3 or H3K27ac (green) in male 2iL
(C) RNA FISH for Xist (red) and Rnf12, Nexmif, or Huwe1 (grayscale) in male 2iL
(D) Quantification of RNA FISH patterns for the X-linked genes Rnf12, Nexmif, or
Huwe1 signal, and pink indicates the absence of Rnf12/Nexmif/Huwe1 signal.
(E) RNA FISH for Xist (red) in female 2iL ESCs at 1.5 days of differentiation in FA
(F) RNA FISH for Xist (red) and Rnf12 or Huwe1 (grayscale) in female 2iL ESCs a
(G) Quantification of RNA FISH patterns for X-linked genes Rnf12 or Huwe1 and X
indicates monoallelic Rnf12/Huwe1 signal, and pink indicates the absence of Rn
(H) Immuno-RNA FISH for Xist (red), NANOG (green), and OCT4 (grayscale) in ma
clouds.
(I) Percentage of NANOG- and OCT4-expressing cells in the population (left) and
Fisher’s exact test was used for statistical analysis. ESC lines used were XY1 an
924 Cell Stem Cell 22, 919–928, June 1, 2018reprogramming intermediates of male EpiSCs using STAT3 acti-
vation (Yang et al., 2010) and Rex1-dGFP reporter activity (Kal-
kan et al., 2017) to induce and monitor reprogramming, respec-
tively (Figures 2F and S3B). As expected, Xist was repressed in
bothmale EpiSCs and control ESCs (Figure 2G). However, in pro-
ductive reprogramming intermediates, Xist was sharply upregu-
lated (Figure 2G) prior to establishment of a consolidated nPSC
identity. It is possible that this is due to loss of tight control of
gene expression. Alternatively, it could reflect the fragile nature
of the nascent naive network during reprogramming.
Male XChromosomeExhibits Hallmarks of XCI uponXist
Upregulation
Next, we analyzed whether the observed Xist upregulation in
males was linked to events associated with the initiation of XCI
as previously described for females. To look at this, we assessed
the nuclear pattern of Xist by RNA FISH. Surprisingly, 1.5 days
after male 2iL ESCs were induced to differentiate in FA, 20%
of cells showed Xist RNA expression. Interestingly, nearly half
of these exhibited XistRNA clouds, with various sizes, character-
istic of XCI (Figure 3A). Although in a smaller proportion, male SL
ESCs induced to differentiate also exhibited cells showing Xist
RNA accumulation (Figure S4A). Appearance of an Xist RNA
cloud duringmale nPSC differentiation has been reported before
(Monkhorst et al., 2008). However, the percentage of cells exhib-
iting this pattern was less than 0.5%, a much smaller proportion
than reported in this study. The difference in the results could be
explained by the homogeneity and robust self-renewal of our 2iL
nPSC cultures and by the choice of time point to conduct the
analysis.
Another event associated with XCI in females is accumulation
of the repressive histone mark trimethyl-H3K27 (H3K27me3)
(Plath et al., 2003; Silva et al., 2003) on the future Xi. Interestingly,
H3K27me3 accumulation was observed in 63% of male cells
showing Xist RNA cloud (Figures 3B, S4B, and S4C).
We then addressed the status of acetyl-H3K27 (H3K27ac),
which is a mark of active enhancers (Creyghton et al., 2010).
This was found hypoacetylated at the male Xist RNA cloud (Fig-
ures 3B, S4B, and S4D). Together, these results indicate that a
silencing epigenetic signature has formed in the Xist-coated
male X chromosome.
To examine whether Xist accumulation was inducing gene
silencing, we performed RNA FISH analysis for nascent tran-
scripts of 5 X-linked genes (Rnf12, Nexmif, Nsdhl, Wbp5, and
Huwe1). The percentage of cells expressing Rnf12, Nsdhl, and
Nexmif was between 3- and 4-fold lower in male cells showing
Xist cloud that in male cells lacking Xist accumulation, and inESCs at 1.5 days of differentiation in FA.White arrowheads indicate Xist cloud.
ESCs at 1.5 days of differentiation in FA.
Huwe1 and Xist as shown in (C). Gray indicates the presence of Rnf12/Nexmif/
using ss probe. Quantification of different Xist RNA patterns is shown.
t 1.5 days of differentiation in FA.
ist as shown in (F). Dark gray indicates biallelic Rnf12/Huwe1 signal, light gray
f12/Huwe1 signal.
le 2iL ESCs at 1.5 days of differentiation in FA. White arrowheads indicate Xist
in cells exhibiting Xist cloud (right) as shown in (H).
d XX1. Scale bar represents 5 mm.
the case of Wbp5, no examples of gene expression were found
at the male X chromosome coated by Xist (Figures 3C, 3D, and
S4E). In contrast, Huwe1 showed no difference. Rnf12, Nsdhl,
Wbp5, and Nexmif are in closer proximity to the Xist locus than
Huwe1 and are also known to be silenced early during XCI, unlike
Huwe1, which is silenced at a late stage (Marks et al., 2015). At
the cell population level, Nexmif was also downregulated (Fig-
ure S4F). However, Xist-mediated silencing did not affect popu-
lation levels of Rnf12 expression (Figure S4F). These data are
consistent with a rapid transient Xist upregulation in males, a
transience that is sufficient to have an impact on early-silencing
genes but not lasting long enough to affect late-silencing ones.
Together these results show that males undergo XCI. which
had so far only been associated with females. However, unlike
females, male XCI is partial, transient, and rapid.
Females Exhibit Partial XCI of Both X Chromosomes at
the Onset of Differentiation
The observed upregulation of Xist in males, which possess only
one X chromosome, questions the existence of a choice mech-
anism preceding initiation of XCI in females. To address this, we
performed Xist RNA FISH in differentiating female nPSCs. Anal-
ysis of these cells in 2iL self-renewing conditions showed that
Xist is not expressed (Figure 1F). Strikingly, at 1.5 days of differ-
entiation, we observed that 30% of the female cells expressing
Xist display RNA accumulation on both X chromosomes (Fig-
ure 3E). Control experiments revealed that 99% of the cells in
this female line have no more than two X chromosomes, demon-
strating that these results cannot be explained by the presence
of tetraploid cells in culture (Figures S1B and S4G).
To assess whether Xist accumulation is inducing gene
silencing on both X chromosomes, we performed RNA FISH
analysis for nascent transcripts of Rnf12 and Huwe1 (Figures
3F and 3G). The incidence of biallelic silencing of Rnf12 was
12-fold greater in female cells exhibiting Xist RNA accumulation
on both X chromosomes than in cells not expressing Xist, while
Huwe1 showed no difference.
These results indicate that the choice of which X chromosome
is going to be irreversibly silenced may follow rather than pre-
cede the initiation of XCI.
Transient Xist RNA Patterns Occur as Differentiating
Cells Become NANOG Negative
To investigate whether Xist upregulation is consistent with a
particular differentiation stage, we analyzed the expression of
NANOG and OCT4 relative to Xist at the single-cell level. Due
to asynchrony in nPSC differentiation, NANOG expression was
variable while most cells remained OCT4-high at 1.5 days. Inter-
estingly, Xist upregulation in males occurred in cells that were
NANOG-low or -negative (Figures 3H and 3I). Likewise, we found
biallelic Xist upregulation in female cells that were OCT4-high/
NANOG-low or -negative (Figures S4H and S4I). The expression
of active CASPASE-3, which is an early marker of apoptosis, was
evaluated to confirm the viability of the Xist-positive male cells.
Importantly, all analyzed Xist-positive cells were negative for
active CASPASE-3 (Figure S4J).
These results are in agreement with a transient Xist upregula-
tion occurring in a defined developmental window and in close
relationship with the downregulation of the naive network.In Vivo Transient Xist Expression in Males and in
Females on Both X Chromosomes
The embryonic day 4.5 (E4.5) naive epiblast is molecularly and
functionally highly similar to in vitro 2iL nPSCs (Boroviak et al.,
2015). Given the observed transient upregulation ofXistRNAdur-
ing nPSC differentiation, we investigated whether this also oc-
curs during in vivo differentiation of the pluripotent naive epiblast.
In agreementwith our findings in nPSCs,we found that E4.5 naive
epiblast cells do not display Xist expression in either sex (Fig-
ure 4A). FromE4.5, theembryo starts implanting andnaiveplurip-
otent gene expression is rapidly downregulated (Boroviak et al.,
2015). Thus, we analyzed E5.5 male and female post-implanta-
tion embryos as a naive epiblast differentiation time point. At
E5.5, we also failed to detect Xist expression in males, whereas
female cells already exhibited one Xist RNA cloud in nearly all
cells, which is the pattern associated with female differentiated
cells. This led us to analyze earlier time points. Interestingly, at
E4.75–E5.0, we found 1–3 cells per male epiblast exhibiting Xist
RNA expression (Figure 4B). When analyzing female epiblast
cells for the same time points, we observed that Xistwas bialleli-
cally expressed in 10% of the epiblast cells showing Xist expres-
sion (Figures 4B and 4C). Together, these data are indicative that
at implantation stage, and correlating with the downregulation of
the naive epiblast network, male and female epiblast cells un-
dergo transient and rapid monoallelic and biallelic expression
of Xist respectively.
DISCUSSION
Our results show that Xist is fully repressed in both male and fe-
male nPSCs provided they have a robust naive TF network. This
may be the result of a combination of direct and indirect mech-
anisms at the XIC, which contains multiple genomic binding sites
occupied by naive pluripotent-associated TFs located at the Xist
locus and at other non-coding and coding genes involved in Xist
regulation (Sa´nchez-Castillo et al., 2015).
We showed that Xist accumulates transiently at the male X
chromosome and induces partial epigenetic and transcriptional
silencing in early differentiating cells.Wehave also demonstrated
that this is linked to downregulation of the naive TF network. In
this context, known positive regulators of Xist, such as Jpx
(Tian et al., 2010), Ftx (Chureau et al., 2011), and RNF12 (Jonkers
et al., 2009; Barakat et al., 2017), may transiently gain the upper
hand and drive Xist expression. However, Xist is subsequently
rapidly suppressed, suggesting that other mechanisms of Xist
silencing are readily available. In agreement with this, deletion
of Tsix, one of the non-coding RNAs implicated in Xist silencing,
was previously found to correlate with the presence of an Xist
RNA cloud in a proportion of differentiating male nPSCs (Sado
et al., 2002). Likewise, Dnmt1mutant nPSCs exhibit Xist upregu-
lation and silencing of X-linked genes in differentiating male cells
(Beard et al., 1995; Panning and Jaenisch, 1996).
It has been proposed that initiation of XCI is related to the X
chromosome/ploidy ratio (Monkhorst et al., 2008). Our study
proposes downregulation of the naive TF network as the trigger
for the initiation of XCI. It will now be interesting to investigate
how these relate to each other.
XCI is defined as having five key phases in the following order:
counting, choice, initiation, spreading, and maintenance (AuguiCell Stem Cell 22, 919–928, June 1, 2018 925
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Figure 4. Xist Is Transiently Upregulated Monoallelically in Males and Biallelically in Females In Vivo
(A and B) RNA FISH for Xist in representative male and female epiblasts of embryos at E4.5 and E5.5 (A) and at E4.75–E5.0 (B).
(B) Examples of cells with monoallelic Xist expression in males and biallelic expression in females are delineated with yellow dashed lines. Higher magnification of
these cells is displayed in the bottom panels.
(C) Percentage of cells with biallelic Xist over total number of epiblast cells expressing Xist in female embryos at indicated developmental stages. Error bars
represent ± SD.
Scale bar represents 10 mm.et al., 2011). However, our data suggest that counting and choice
between the two X chromosomes is not a requirement for XCI
initiation. Furthermore, we show that the initiation and spreading
phases also occur in males. Importantly, the initiation and
spreading of XCI in males take place within a defined window
of time where the process of XCI is known to be reversible
(Wutz and Jaenisch, 2000), meaning that as long as Xist926 Cell Stem Cell 22, 919–928, June 1, 2018expression ceases within 3 days of differentiation, any induced
changes on the X chromosome are fully reversible. Consistent
with this, our data showed that Xist expression was already
downregulated by day 3 of male cell differentiation. Therefore,
we hypothesize that in the mouse species a counting mecha-
nism, which relies on gender differences during the reversible
period, occurs after XCI initiation.
It has been proposed that initiation of XCI in females is pre-
ceded by pairing of the two XIC loci and that the process of
choice was dependent on pairing, therefore restricting XCI to fe-
male cells (Bacher et al., 2006; Xu et al., 2006). Moreover,
although the negative regulation of Xist by the naive TF network
is the same in male and female cells, the X-linked Xist activators
adjacent to Xist and known to also work in trans will be dupli-
cated in females. These and other mechanisms must somehow
ensure that all but one X chromosome undergo irreversible XCI. It
will now be important to further understand how these mecha-
nisms allow XCI to be maintained in females only.
Human naive-like cells and human embryos cultured in vitro
were found to have an intriguing Xist pattern (Petropoulos
et al., 2016; Sahakyan et al., 2017; Vallot et al., 2017). In both
cases, the presence of one or two Xist RNA clouds was reported
for a proportion of male and female cells, respectively. As sug-
gested by the authors, this may indicate species differences.
However, it may also be akin to what we are reporting here,
that is, as a result of a perturbed naive TF network, human naive
cells may exhibit monoallelic and biallelic Xist upregulation in
both males and females respectively.
In conclusion, our study redefines the paradigm of XCI and
opens up new avenues to investigate how this process is
regulated.
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Monoclonal mouse anti-alpha-Tubulin Abcam Cat# ab7291, RRID:AB_2241126
Polyclonal rabbit anti-Nanog Bethyl Laboratories Cat# A300-397A, RRID:AB_386108
Monoclonal rat anti-Nanog ThermoFisher Scientific Cat# 14-5761-80, RRID:AB_763613
Monoclonal rabbit anti-Oct4 Cell Signaling Technology Cat# 83932, RRID:AB_2721046
Polyclonal goat anti-Oct4 Santa Cruz Biotechnology Cat# sc-8628, RRID:AB_653551
Monoclonal rabbit anti-Phospho-Stat3 (Tyr705) Cell Signaling Technology Cat# 9145, RRID:AB_2491009
Polyclonal rabbit anti-H3K27me3 Merck Millipore Cat# 07-449, RRID:AB_310624
Polyclonal rabbit anti-H3K37ac Abcam Cat# ab4729, RRID:AB_2118291
Monoclonal rabbit anti-Cleaved Caspase-3 (Asp175) Cell Signaling Technology Cat# 9664, RRID:AB_2070042
Polyclonal rabbit anti-Rnf12 Merck Millipore Cat# ABE1949, RRID:AB_2721047
HPR-conjugated donkey anti-rabbit GE Healthcare Cat# NA934, RRID:AB_772206
HPR-conjugated sheep anti-mouse GE Healthcare Cat# NA931, RRID:AB_772210
HPR-conjugated donkey anti-goat Santa Cruz Biotechnology Cat# sc-2020, RRID:AB_631728
Donkey anti-rabbit IgG (H+L) Highly Cross-Adsorbed
Secondary Antibody, Alexa Fluor 488
ThermoFisher Scientific Cat# A-21206, RRID:AB_2535792
Donkey anti-Rabbit IgG (H+L) Highly Cross-Adsorbed
Secondary Antibody, Alexa Fluor 647
ThermoFisher Scientific Cat# A-31573, RRID:AB_2536183
Donkey Anti-Rat IgG (H+L) Highly Cross-Adsorbed
Secondary Antibody, Alexa Fluor 488
ThermoFisher Scientific Cat# A-21208, RRID:AB_2535794
Goat biotinylated anti-Avidin Vector Laboratories Cat# BA-0300, RRID:AB_2336108
Chemicals, Peptides, and Recombinant Proteins
N2 Cambridge Stem Cell Institute N/A
B27 ThermoFisher Scientific Cat# 17504044
Murine LIF Hyvo¨nen lab, Cambridge N/A
CHIR99021 Stewart lab, Dresden N/A
PD0325901 Stewart lab, Dresden N/A
FBS Labtech Cat# FB-1001S/500
Egf Peprotech Cat# 315-09
Fgf2 Hyvo¨nen lab, Cambridge N/A
Activin A Hyvo¨nen lab, Cambridge N/A
XAV 939 Tocris, Bio-techne Cat# 3748
4-Hydroxytamoxifen Sigma-Aldrich Cat# 7904
InSolution JAK Inhibitor I Merck-Millipore Cat# 420097
GCSF Peprotech Cat# 300-23
KaryoMAX Colcemid Solution in HBSS ThermoFisher Scientific Cat# 15210040
Taq DNA Polymerase QIAGEN Cat# 201205
Critical Commercial Assays
DNeasy Blood & Tissue Kit QIAGEN Cat# 69504
RNeasy Mini Kit QIAGEN Cat# 74104
SuperScript III First-Strand Synthesis SuperMix ThermoFisher Scientific Cat# 18080400
TaqMan Fast Universal PCR Master Mix (2X), no
AmpErase UNG
ThermoFisher Scientific Cat# 4352042
Esrrb TaqMan Gene Expression Assay ThermoFisher Scientific Mm00442411_m1
Ftx TaqMan Gene Expression Assay ThermoFisher Scientific Mm03455830_m1
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Gapdh TaqMan Gene Expression Assay ThermoFisher Scientific 4352339E
Klf2 TaqMan Gene Expression Assay ThermoFisher Scientific Mm01244979_g1
Klf4 TaqMan Gene Expression Assay ThermoFisher Scientific Mm00516104_m1
Klf5 TaqMan Gene Expression Assay ThermoFisher Scientific Mm00456521_m1
Nanog TaqMan Gene Expression Assay ThermoFisher Scientific Mm02384862_g1
Nexmif TaqMan Gene Expression Assay ThermoFisher Scientific Mm01239465_g1
Oct4 TaqMan Gene Expression Assay ThermoFisher Scientific Mm00658129_gH
Rex1 TaqMan Gene Expression Assay ThermoFisher Scientific Mm03053975_g1
Rnf12 TaqMan Gene Expression Assay ThermoFisher Scientific Mm00488044_m1
Socs3 TaqMan Gene Expression Assay ThermoFisher Scientific Mm01249143_g1
Sox2 TaqMan Gene Expression Assay ThermoFisher Scientific Mm03053810_s1
Tfcp2l1 TaqMan Gene Expression Assay ThermoFisher Scientific Mm00470119_m1
Xist TaqMan Gene Expression Assay ThermoFisher Scientific Mm01232884_m1
Biotin-Nick Translation Mix Sigma-Aldrich Cat# 11745824910
Illustra MicroSpin S-300 HR columns GE Healthcare Cat# 27513001
Salmon Sperm DNA, sheared ThermoFisher Scientific Cat# AM9680
Mouse Cot-1 DNA ThermoFisher Scientific 18440016
Ribonucleoside Vanadyl Complex New England Biolabs S1402S
Texas Red Avidin DCS Vector Laboratories A-2016
Mouse Xist Stellaris RNA FISH Probe with
Quasar 570 Dye
BioSearch Technologies Cat# SMF-3011-1
Mouse Xist Stellaris RNA FISH Probe with
Quasar 670 Dye
BioSearch Technologies Cat# VSMF-3095-5
Custom Stellaris RNA FISH Probe with FISH
Probe with Quasar 570 Dye
BioSearch Technologies Cat# SMF-1063-5
Mouse Chromosome X Whole Chromosome
Painting Probe, Green Label
MetaSystems Probes Cat# D-1420-050-FI
Mouse Chromosome Y Whole Chromosome
Painting Probe, Orange Label
MetaSystems Probes Cat# D-1421-050-OR
Deposited Data
RNA seq data This paper GEO: GSE109173
Experimental Models: Cell Lines
E14tg2a ESC line Smith lab, Cambridge N/A
EFC ESC line Smith lab, Cambridge N/A
LF1 ESC line Smith lab, Cambridge N/A
LF2 ESC line Smith lab, Cambridge N/A
C6 ESC line Smith lab, Cambridge N/A
Nanogflox/, Rosa26-CreERT2 ESC line This paper N/A
Oct4flox/, Rosa26-CreERT2 ESC line This paper N/A
Rex1-dGFP EpiSC line This paper N/A
Rex1-dGFP NSC line This paper N/A
Nanog-GFP EpiSC line Smith lab, Cambridge N/A
Experimental Models: Organisms/Strains
Mouse CD-1 Charles River Cat# 022
Oligonucleotides
Gender PCR primer Ube1XA (50 to 30): TGGTC
TGGACCCAAACGCTGTCCACA
(Chuma and Nakatsuji, 2001) N/A
Gender PCR primer Ube1XB (50 to 30): GGCA
GCAGCCATCACATAATCCAGATG
(Chuma and Nakatsuji, 2001) N/A
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Software and Algorithms
Fiji Open Source http://imagej.net/Fiji/Downloads
R The R Project https://www.r-project.org/
GraphPad Prism 6 GraphPad Software https://www.graphpad.com/scientific-
software/prism/
FlowJo FlowJo, LLC https://www.flowjo.com/
TrimGalore Babraham Institute http://www.bioinformatics.babraham.ac.uk/
projects/trim_galore
TopHat2 Johns Hopkins University https://ccb.jhu.edu/software/tophat
featureCounts Walter and Eliza Hall Institute
of Medical Research
http://bioinf.wehi.edu.au/featureCounts
DESeq2 Bioconductor https://bioconductor.org/packages/release/
bioc/html/DESeq2.htmlCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to andwill be fulfilled by the Lead Contact, Jose´ Silva
(jcs64@cam.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines
Male wild-type ESC lines included E14tg2a (XY1) and EFC (XY2). Female wild-type ESC lines included LF1 (XX1), LF2 (XX2) and C6
(XX3). The cell sorting experiment was performed in maleNanog-GFP ESCs. FemaleNanog-GFP EpiSCs were used as control in Xist
RNA FISH.Nanog deletion was performed in male and femaleNanogflox/-, Rosa26-CreERT2 ESC lines.Oct4 deletion was performed
inmale and femaleOct4flox/-, Rosa26-CreERT2 ESC lines. Male iPSC line usedwas derived fromRex1-dGFPNSCs. Reprogramming
was performed in male Rex1-dGFP EpiSCs.
Cell culture
Mouse ESCs and iPSCs were cultured in 2i+LIF (2iL), 2i, or serum+LIF (SL) as indicated. 2iL medium was composed of N2B27, 3 mM
CHIR99021, 1 mM PD0325901 (Stewart lab, Dresden), and 20 ng ml1 of murine LIF (Hyvo¨nen lab, Cambridge). N2B27 medium
comprised 1:1 DMEM/F-12 and Neurobasal (ThermoFisher Scientific), 2 mM L-glutamine (ThermoFisher Scientific), 1x penicillin-
streptomycin (Sigma-Aldrich), 0.1 mM 2-mercaptoethanol (ThermoFisher Scientific), 1% B27 (ThermoFisher Scientific) and 0.5%
N2 (homemade). SL medium contained GMEM (Sigma-Aldrich), 10% fetal bovine serum (Labtech), 1x non-essential amino acids
(ThermoFisher Scientific), 1 mM sodium pyruvate (Sigma-Aldrich), 2 mM L-glutamine, 1X penicillin-streptomycin, 0.1 mM 2-mercap-
toethanol and 20 ng ml1 of LIF. EpiSCs were cultured in FAX medium composed of N2B27 supplemented with 12.5 ng ml1 Fgf2,
20 ng ml1 Activin A (Hyvo¨nen lab, Cambridge) and 6.25 mg ml1 XAV 939 (Bio-Techne). 4-OHT (Sigma-Aldrich) was used at a con-
centration of 500 nM and InSolution JAKi I (Merck Millipore) at a concentration of 1 mM. During expansion of Nanogflox/- cell lines,
selection with 200 mg ml1 G418 (ThermoFisher Scientific) was applied to select for pluripotent cells based on Nanog promoter
activity at the null allele. For ESCs and iPSCs, tissue-culture flasks were coated with 0.1% gelatin (Sigma-Aldrich) in PBS (Sigma-
Aldrich). For EpiSCs, tissue-culture flasks were coated with 10 mg ml1 fibronectin (Merck Millipore) in PBS (Sigma-Aldrich).
Cell differentiation
For embryoid body differentiation, 1.53 106 cells were plated on 10 cm low-attachment dishes in serum-containing mediumwithout
LIF. For differentiation in adherent monolayer culture, 63 105 cells were plated on gelatin-coated 10 cmdishes in serum-free (N2B27)
or N2B27 supplemented with Fgf2 and Activin A (FA). XY1 and XX1 ESCs were not passaged more than 3 times in 2iL prior to the
differentiation assays.
Reprogramming
Embryo-derivedmaleEpiSCswithRex1+/dGFP reporter (Kalkan et al., 2017)were used that constitutively express theGY118F recep-
tor transgeneknown todriveEpiSC reprogramming viaSTAT3activation (Yanget al., 2010). For reprogramming,EpiSCswereplatedat
10,000 cells per fibronectin-coated 6-well in FAX maintenance medium. The following day, reprogramming was induced by switch to
2iL plus GCSF (30 ng ml1 human GCSF, Peprotech). On days 2, 3, 4, 5 and 6, multiple reprogramming wells were harvested using
accutase, stained with DAPI to eliminate nonviable cells, and sorted by flow cytometry to isolate the Rex1-dGFP-positive subpopula-
tion for further analysis. Parental EpiSCsandmaleRex1+/dGFPESCswere usedas negative andpositive gating controls respectively.Cell Stem Cell 22, 919–928.e1–e6, June 1, 2018 e3
Embryos
Embryos were collected from CD1 female mice (Charles River Laboratories, UK). Use of animals in this project was approved by the
Animal Welfare and Ethical Review Body for the University of Cambridge (Procedure Project Licenses P76777883 and 80/2597).
METHOD DETAILS
RNA isolation, cDNA synthesis and qRT-PCR
Total RNA was isolated from cells using the RNeasy mini kit (QIAGEN) in accordance with the manufacturer’s protocol. One micro-
gram of total RNA was reverse-transcribed using SuperScript III First-Strand Synthesis SuperMix (ThermoFisher Scientific). Reverse
Transcription Quantitative Real-Time PCR (qRT-PCR) reactions were set up in triplicate using TaqMan Universal PCR Master Mix
(ThermoFisher Scientific) and TaqMan gene expression assays (ThermoFisher Scientific). qRT-PCR experiments were performed
on a StepOnePlus Real Time PCR System (ThermoFisher Scientific). Delta Ct (DCt) values compared to Gapdh were calculated
and relative quantities calculated as 2 to the power of -DCt. The means of three values were calculated and normalized as indicated.
Flow cytometry
Nanog-GFP ESCs were resuspended in PBS containing 3.5% BSA (ThermoFisher Scientific) and sorting was performed using a
MoFlo high-speed cell sorter (Beckman Coulter). A 514/10BP filter was used for GFP and a 580/30BP filter was used for autofluor-
escence. Rex1-dGFP positive reprogramming intermediates were sorted using a BD Influx 5 cell sorter (BD Biosciences). A 460/50
filter was used for DAPI and a 530/40 filter was used for GFP.
DNA extraction
In the case of the cell lines, DNA was isolated using the DNeasy Blood & Tissue Kit (QIAGEN) in accordance with the manufacturer’s
protocol. In the case of the embryos, these were collected from the slides after RNA FISH and imaging and then lysed in 0.2% Triton
X-100 and Proteinase K at 56C for 10 minutes followed by 95C for 15 minutes.
Gender PCR
Cell lines were sexed by PCR using primers Ube1XA and Ube1XB, which results in two products of distinct sizes from the Ube1x and
Ube1y genes on the X and Y chromosome respectively (Chuma andNakatsuji, 2001) . PCR reactionswere performed in a final volume
of 20 mL with 100 ng of DNA, 1X CoralLoad buffer, 0.2 mM dNTPs, 0.35 mMprimers and 2.5 units Taq DNA Polymerase (QIAGEN) and
run on a thermal cycler with the following conditions: 94C for 3minutes, 30 cycles with 94C for 30 s, 66C for 30 s, and 72C for 30 s,
followed by 72C for 10 minutes. In the case of the embryos 4 mL per embryo lysate were added to the PCR reaction. Products were
electrophoresed on 2% agarose gel.
Western blotting
Dissociated cells were lysed in RIPA buffer (as described by Sigma-Aldrich) containing Complete-ULTRA protease-inhibitor and
PhosStop phosphatase-inhibitor cocktails (Roche), and sonicated with Bioruptor200 (Diagenode) at high frequency, alternating
30 s on/off for 3 minutes. SDS-PAGE electrophoresis was performed using Bolt 10% Bis-Tris Plus gels (ThermoFisher Scientific)
in a NovexMiniCell (ThermoFisher Scientific). Protein transfer was performed using semi-dry iBlot 2 system (ThermoFisher Scientific)
and iBlot Transfer Stacks (ThermoFisher Scientific). The following primary antibodies dilutions were used: mousemonoclonal against
a-Tubulin (1:5,000) from Abcam, rabbit polyclonal against NANOG (1:5,000) from Bethyl Laboratories, rabbit monoclonal against
p-Y705-STAT3 (1:1,000) from Cell Signaling Technology, rabbit polyclonal against RNF12 (1:1,000) from Merck Millipore, and
goat polyclonal against OCT4 (1:1,000) from Santa Cruz Biotechnology. Detection was achieved using HRP-linked secondary anti-
bodies against the appropriate species (GE Healthcare) and ECL Plus Western Blotting Detection System (GE Healthcare).
Xist RNA FISH with double-stranded probe
Cells were plated on SuperFrost Plus Adhesion slides (ThermoFisher Scientific) and permeabilised in cytoskeletal buffer
(100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 10 mM PIPES) containing 0.5% Triton X-100 (Sigma-Aldrich), 1 mM EGTA pH 8
and vanadyl ribonucleoside (New England Biolabs) for 5 minutes on ice. They were subsequently fixed in 4% paraformaldehyde
(Sigma-Aldrich) for 10minutes, brieflywashed in 1X PBS and dehydrated through 70, 80, 95, and 100%ethanol, after which the slides
were air-dried. At this stage, a denatured Xist probe was applied onto the slides and these were incubated overnight at 37C.
The probewas prepared by labeling plasmid DNAcontaining amouseXist exon 1 fragment sequence (kindly provided by Professor
Neil Brockdorff, University of Oxford, UK) with a Biotin-Nick TranslationMix (Sigma-Aldrich) according tomanufacturer’s instructions
and non-incorporated nucleotideswere removedwith IllustraMicroSpin S-300 HR columns (GEHealthcare). To 20 ng of probe, 10 mg
of sheared salmon spermDNA (ThermoFisher Scientific) and 3 mg of mouse Cot-1 DNA (ThermoFisher Scientific) were added. Finally,
the probe was dehydrated by vacuum and resuspended in deionized formamide (VWR). Before applying to the slide, the probe was
denatured at 80C and 2X hybridization buffer (4X SSC, 20% dextran sulfate, 2 mg ml-1 BSA, 2 mM vanadyl ribonucleoside)
was added.
The following day, the slides were washed at 42C in 2X SSC/50% formamide for 15 minutes, then three times in 2X SSC for 5 mi-
nutes each. They were then transferred to 4X SSC/0.1% Tween 20 at room temperature and blocked in 4 mg ml-1 BSA ine4 Cell Stem Cell 22, 919–928.e1–e6, June 1, 2018
4X SSC/0.1% Tween 20 at 37C for 30 minutes. Probe detection was performed by first applying Avidin conjugated to Texas Red
(1:500, Vector Laboratories), then a biotinylated anti-avidin antibody (1:200, Vector Laboratories), followed by a second layer of
Avidin-Texas Red. All detection reagents were diluted in 4 mg ml-1 BSA in 4X SSC/0.1%Tween 20 and incubated at 37C for 30 mi-
nutes followed by three washes in 4X SSC/0.1% Tween 20 in between each step. Finally, the slides were mounted in Vectashield
Mounting Medium containing DAPI (Vector Laboratories).
RNA FISH with single-stranded probe
RNA FISH protocol was modified from the Stellaris (Biosearch Technologies) protocol for adherent mammalian cells. Cells were
plated on SuperFrost Plus Adhesion slides (ThermoFisher Scientific) and fixed in 4% PFA (Sigma-Aldrich) at room temperature for
10 minutes. They were subsequently washed in 1X PBS and permeabilised in cytoskeletal buffer (100 mM NaCl, 300 mM sucrose,
3 mMMgCl2, 10 mM PIPES) containing 0.5% Triton X-100, 1 mM EGTA pH 8 and vanadyl ribonucleoside (New England Biolabs) for
5 minutes on ice. Following washing in 1X PBS, they were incubated in 70% ethanol at 4C overnight. Cells were incubated in 10%
formamide (VWR) in 2X SSC (Sigma-Aldrich) for 10 minutes and then in 250 nM Stellaris Probes diluted in 100 mg mL1 dextran sul-
fate (MPBiomedicals) and 10% formamide in 2X SSC at 37Covernight. Xistwas recognized using Stellaris FISH Probes labeled with
either Quasar 570 or Quasar 670 (BioSearch Technologies). Rnf12,Nexmif,Nsdhl,Wbp5 andHuwe1were recognized using Custom
Stellaris FISH Probes labeled with Quasar 570 (BioSearch Technologies). The sequences of 48 oligonucleotides designed against
unique intronic sequences using the online Stellaris Probe Designer tool (BioSearch Technologies). The Rnf12 and Huwe1 probes
sequences were kindly provided by Prof. Neil Brockdorff and Dr. Tatyana Nesterova (University of Oxford, UK). After hybridization,
cells were incubated in 10% formamide in 2X SSC at 37C for 30 minutes followed by a wash in 2X SSC at room temperature for
5 minutes. Cells were mounted with Vectashield Antifade Mounting Medium with DAPI (Vector Laboratories).
RNA FISH of mouse embryos
Mouse embryos were collected from CD1 mice and fixed in 4% PFA at room temperature for 15 minutes. Embryos were further pro-
cessed for RNA FISH using Stellaris probes (BioSearch Technologies) according to the procedure described above.
Immunofluorescence
Immunofluorescence was always performed in combination with RNA FISH using Stellaris probes. Sequential immunofluorescence
and RNA FISH protocol was modified from the Stellaris (Biosearch Technologies) protocol for adherent mammalian cells. Cells were
fixed and permeabilised as for RNA FISH. Theywere thenwashed in 1XPBS and incubatedwith primary antibody diluted in 1XPBS at
37C for 2 hours. Primary antibodies were used as follows: rabbit polyclonal against H3K27me3 (1:500) from Merck Millipore, rabbit
polyclonal against H3K27ac (1:500) from Abcam, rat monoclonal against NANOG (1:300) from ThermoFisher Scientific, rabbit mono-
clonal against OCT4 (1:300) from Cell Signaling Technology and rabbit monoclonal against cleaved CASPASE-3 (1:100) from Cell
Signaling Technology. Following washing in 1X PBS, cells were incubated with secondary antibody diluted in 1X PBS at 37C for
1 hour. An appropriate Alexa Fluor conjugated secondary antibody (1:1,000) from ThermoFisher Scientific was used. Cells were
then washed in 1X PBS and fixed again in 4% PFA at room temperature for 10 minutes. Following washing with 1X PBS, RNA
FISH protocol was carried out as described above, starting from the incubation in 10% formamide in 2X SSC.
Metaphase spread
ESCs were plated onto a gelatinised 6-well 2 days prior preparation of the chromosome spreads. Cultures were then arrested in
metaphase by addition of 0.5 mg mL1 KaryoMAX colcemid (ThermoFisher Scientific) and incubation at 37C for 3 hours. Cell
were then washed in PBS, harvested with accutase and centrifuged at 300 g for 5 minutes. Following aspiration of the supernatant,
the pellet was resuspended in 5 mL of 0.075 M KCl solution and incubated at 37C for 15 minutes. Then 100 mL of ice cold metha-
nol:glacial acetic acid (3:1) fixative solution were added drop-wise followed by an incubation on ice for 10 minutes. Following incu-
bation, cells were centrifuged at 300 g for 5minutes, supernatant was aspirated leaving 500 mL in the tube and 5mL of fixative solution
were added to the cells. Again 500 mL of the supernatant were kept in the tube after centrifugation and spread onto a glass slide. After
at least 3 hours at room temperature, the slide was stained or stored at 20C for further analysis.
DNA FISH chromosome painting
Prior to X and Y chromosome painting, immune RNA FISH was performed, slides were imaged and x-y coordinates were marked for
future reference. After removal of the coverslip, slides were washed in 2X SSC at room temperature. X and Y chromosome painting
was also performed on metaphase spreads. Slides were dehydrated through an ice-cold ethanol series (70%, 80%. 95% and 100%)
for 3 minutes each and then allowed to air dry. X and/or Y chromosome paint probe (Metasystems) was added to the slide, denatur-
ation was carried out at 75C for 2 minutes and slides were incubated at 37C overnight. After hybridization, slides were incubated in
0.4X SSC at 72C for 2 minutes followed by a wash with 0.05% Tween-20 in 2X SSC at room temperature for 30 s. Slides were rinsed
in water, allowed to air dry and mounted with Vectashield Antifade Mounting Medium with DAPI (Vector Laboratories).
Microscopy and image analysis
Images were taken with an Eclipse Ti Spinning Disk confocal microscope (Nikon) equipped with an Andor Revolution XD System
using either 40X or 60X objectives. Images were processed and analyzed with ImageJ. Presented images are maximum intensityCell Stem Cell 22, 919–928.e1–e6, June 1, 2018 e5
projections of Z stack slices or, in the case of embryos, selected Z stack slices. Scoring of RNA FISH signals was done by eye from
images.
RNA-seq
RNA integrity was assessed on a Qubit Fluorometer (ThermoFisher Scientific) and Agilent Bioanalyzer Nano Chips (Agilent Technol-
ogies). Depletion of ribosomal RNA was performed on 2-5 mg of total RNA using the Ribo-Zero rRNA Removal Kit (Illumina) and
libraries were produced from 10-100ng of ribosomal-depleted RNA using NextFlex Rapid Directional RNA-seq Kit (Bioo Scientific)
with 12 cycles of PCR amplification. Libraries were pooled in equimolar quantities and sequenced on the HiSeq4000 platform
(Illumina) at CRUK.
QUANTIFICATION AND STATISTICAL ANALYSES
Where indicated, statistical analysis was performed by Fisher’s exact test using GraphPad Prism. ‘‘n’’ values in figures represent the
number of embryos or number of cells analyzed. All qRT-PCR data represent the mean of three technical replicates. All error bars
represent ± standard deviation (SD).
RNA-seq analysis
RNA-seq reads were adaptor-trimmed with TrimGalore (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore) and map-
ped to the mouse reference genome (GRCm38/mm10) with TopHat2 (https://ccb.jhu.edu/software/tophat) allowing for one
mismatch and alignments guided by Ensembl gene models (Ensembl release 82). Strand-specific read counts were obtained with
featureCounts (http://bioinf.wehi.edu.au/featureCounts). Transcript counts were normalized, and the statistical significance of differ-
ential expression between samples was assessed using the R Bioconductor DESeq2 package (https://bioconductor.org/packages/
release/bioc/html/DESeq2.html). Transcript counts normalized by DESeq2 size factors were subsequently normalized by their
length/1000. Principal component analysis (PCA) was performed by singular value composition using the R prcomp() function on
scaled expression values.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq data reported in this paper is GEO: GSE109173.e6 Cell Stem Cell 22, 919–928.e1–e6, June 1, 2018
Cell Stem Cell, Volume 22Supplemental InformationExit from Naive Pluripotency Induces a Transient
X Chromosome Inactivation-like State in Males
Elsa J. Sousa, Hannah T. Stuart, Lawrence E. Bates, MohammadmersadGhorbani, Jennifer
Nichols, Sabine Dietmann, and José C.R. Silva
KXX
3 n
PS
Cs
XY
1 n
PS
Cs
Klf2
SL P1 P2 P3
0.0
0.5
1.0
1.5
XX1
XX2
XY1
XY2
Esrrb
SL P1 P2 P3
0.0
0.5
1.0
1.5C Klf4
SL P1 P2 P3
0.0
0.5
1.0
1.5
Re
lati
ve
 to
G
ap
dh
 an
d
no
rm
aliz
ed
 to
 th
e h
igh
es
t v
alu
e
Socs3
3 5
0.0
0.5
1.0
1.5
Socs3
Time (days)
3 5
0.0
0.2
0.4
0.6
0.8
2iL 2iL 2iL 2iL
2iL
2i
1 µM JAKi + 2i
0 6 2412 48 72Hours
NANOG
α-TUBULIN
+ 4-OHT
XX Nanogflox/-
nPSCs
NANOG XY Nanogflox/-
nPSCsα-TUBULIN
p-STAT3
α-TUBULIN
p-STAT3
XX3 nPSCs
XY1 nPSCs
α-TUBULIN
A
XX
1
XX
2
XY
1
XY
2
X band
Y band
XX
3
Re
lati
ve
 to
G
ap
dh
 an
d
no
rm
aliz
ed
 to
 0 
hr
X band
Y band
XY
 N
an
og
-G
FP
nP
SC
s
XX Ep
iSC
XX XY
D E
X band
F
X band
Y band
G
H
XX
Time (hours)
Re
lati
ve
 to
G
ap
dh
an
d
no
rm
aliz
ed
 to
 th
e h
igh
es
t v
alu
e
0 24 48 72 96
0.0
0.5
1.0
1.5 XY
Time (hours)
0 24 48 72 96
0.0
0.5
1.0
1.5
Nanog
Klf2
Rex1
I J
X band
Y band
L N
B
Nanogflox/-nPSCs
XY
1 n
PS
Cs
XX
1 n
PS
Cs
X Chr/Y Chr/DAPI
X band
XX XY
Oct4flox/-nPSCs
Nanogflox/- Rosa26-CreERT2 nPSCs + 4-OHT
Oct4flox/- Rosa26-CreERT2 nPSCs + 4-OHT
XX Oct4flox/-
nPSCs
XY Oct4flox/-
nPSCs
OCT4
α-TUBULIN
OCT4
α-TUBULIN
0 6 2412 48 72Hours
+ 4-OHT
96
M
Figure S1. Xist expression is abolished by a robust naive pluripotent network, Related 
to Figure 1. 
(A) PCR-based gender determination of the cell lines LF1 (XX1), LF2 (XX2), E14tg2a (XY1), 
and EFC (XY2). 
(B) X (green) and Y (red) DNA FISH chromosome painting of metaphase spreads of the 
ESC lines LF1 (XX1) and E14tg2a (XY1). 
(C) qRT-PCR analysis of naive markers (Tfcp2l1, Esrrb, Klf4, and Klf2) in two female, LF1 
(XX1) and LF2 (XX2), and two male, E14tg2a (XY1) and EFC (XY2), ESC lines in SL versus 
2iL conditions. P indicates the number of passages in 2iL. Data shown are the mean of 3 
technical replicates. Error bars represent ± SD.  
(D) PCR-based gender determination of the Nanog-GFP ESC line. 
(E) PCR-based gender determination of the control EpiSC line. 
(F) PCR-based gender determination of the Nanogflox/-, Rosa26-CreERT2 ESC lines.  
(G) Western blot analysis of NANOG in female and male Nanogflox/-, Rosa26-CreERT2 ESCs 
in 2iL (0 hours) and at different time points following treatment with 4-OHT.  
(H) qRT-PCR analysis of naive markers (Esrrb, Klf4, Klf5, Sox2, Tfcp2l1, Rex1, and Oct4) in 
female and male Nanogflox/-, Rosa26-CreERT2 ESCs in 2iL (0 hours) and at different time 
points following treatment with 4-OHT. Data shown are the mean of 3 technical replicates. 
Error bars represent ± SD. 
(I) PCR-based gender determination of the C6 ESC line (XX3). 
(J) Western blot analysis of p-STAT3 in female (C6 – XX3) and male (E14tg2a – XY1) ESCs 
in 2iL, 2i or after 3 days in 1 µM JAKi + 2i. 
(K) qRT-PCR analysis of the STAT3-target Socs3 and naive markers (Nanog, Oct4, and 
Sox2) in female (C6 – XX3) and male (E14tg2a – XY1) ESCs in 2iL, 2i or after 3 and 5 days 
in 1 µM JAKi + 2i. Data shown are the mean of 3 technical replicates. Error bars represent ± 
SD. 
(L) PCR-based gender determination of the Oct4flox/-, Rosa26-CreERT2 ESC lines.  
(M) Western blot analysis of OCT4 in female and male Oct4flox/-, Rosa26-CreERT2 ESCs in 
2iL (0 hours) and at different time points following treatment with 4-OHT.  
(N) qRT-PCR analysis of naive markers (Nanog, Klf2, and Rex1) in female and male 
Oct4flox/-, Rosa26-CreERT2 ESCs in 2iL (0 hours) and at different time points following 
treatment with 4-OHT. Data shown are the mean of 3 technical replicates. Error bars 
represent ± SD. 
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Figure S2. Xist is transiently and rapidly upregulated in male nPSC differentiation, 
Related to Figure 2. 
(A) qRT-PCR analysis of Xist during differentiation of male (EFC – XY2) ESCs using 
different conditions, and during embryoid body differentiation of male iPSCs derived from 
Rex1-dGFP neural stem cells. Before differentiation, cells were maintained in 2iL. Data 
shown are the mean of 3 technical replicates. Error bars represent ± SD. 
(B) PCR-based gender determination of the iPSC line. 
(C) PCA of differentiating male (E14tg2a – XY1) cells based on differential expression of 
genes that had an expression of at least Log2 (normalized counts) 4.5 in at least one of the 
samples. Before differentiation, ESCs were maintained in 2iL or SL media, as indicated. 
Data was obtained by strand-specific RNA-seq. 
(D) Expression levels are shown during differentiation of male (E14tg2a – XY1) ESCs for 
Xist and other elements of the XIC that have been implicated in the regulation of Xist. Before 
differentiation, ESCs were maintained in 2iL or SL media, as indicated. Data were obtained 
by strand-specific RNA-seq. Scale represents Log2 transformed expression value. 
(E) qRT-PCR analysis of Ftx during differentiation of male (E14tg2a – XY1) ESCs using 
different conditions. Before differentiation, cells were maintained in 2iL. Data shown are the 
mean of 3 technical replicates. Error bars represent ± SD. 
(F) Western blot analysis of RNF12 during differentiation of male (E14tg2a – XY1) ESCs in 
FA. Before differentiation, cells were maintained in 2iL. 
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Figure S3. Expression pattern of long non-coding RNAs in differentiating male nPSCs, 
Related to Figure 2. 
(A) Heatmap depicting the expression profile of long non-coding RNAs during differentiation 
of male (E14tg2a – XY1) ESCs. Before differentiation, ESCs were maintained in 2iL or SL 
media, as indicated. Data was obtained by strand-specific RNA-seq. Scale represents z-
scores of Log2 transformed expression values. Xist is indicated with a red arrow. 
(B) PCR-based gender determination of the Rex1-dGFP EpiSC line. 
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Figure S4. Males undergo transient XCI, Related to Figure 3. 
(A) RNA FISH for Xist (red) in male 2iL ESCs at 1.5 days of differentiation in FA using 
strand-specific probe. Nuclei are shown in blue (DAPI staining). White arrowhead indicates 
the location of the Xist signal. Quantification of the different Xist RNA patterns is shown. 
(B) Immuno RNA FISH for Xist (red) and H3K27me3 or H3K27ac (green) in male 2iL ESCs 
at 1.5 days of differentiation in FA. Nuclei are shown in blue (DAPI staining). White 
arrowheads indicate the location of the Xist cloud.  
(C) Immuno RNA FISH for Xist (red) and H3K27me3 (green) in male 2iL ESCs at 1.5 days of 
differentiation in FA with subsequent DNA FISH XY paint (grayscale). Nuclei are shown in 
blue (DAPI staining). Yellow arrowheads indicate the location of the X chromosome. A cell 
lacking H3K27me3 on the X chromosome is shown as a negative control. 
(D) Immunofluorescence for H3K27ac (green) in male 2iL ESCs at 1.5 days of differentiation 
in FA with subsequent DNA FISH XY paint (grayscale). Nuclei are shown in blue (DAPI 
staining). Yellow arrowheads indicate the location of the X chromosome. A cell showing 
existence of H3K27ac on the X chromosome is shown as a negative control.  
(E) Quantification of the RNA FISH patterns for the X-linked genes Nsdhl or Wbp5 and Xist 
in male 2iL ESCs at 1.5 days of differentiation in FA. Fisher’s exact test was used for 
statistical analysis.   
(F) qRT-PCR analysis of Rnf12, Nexmif, and Nanog during differentiation in FA of female 
(LF1 – XX1) and male (E14tg2a – XY1) ESCs. Before differentiation, cells were maintained 
in 2iL. Data shown are the mean of 3 technical replicates. Error bars represent ± SD. 
(G) RNA FISH in female (LF1) 2iL ESCs with a strand-specific probe detecting X-encoded 
nascent RNA of Huwe1 (grayscale). Nuclei are shown in blue (DAPI staining). Quantification 
of the different RNA FISH patterns is shown.  
(H) Immuno RNA FISH for Xist (red), NANOG (green) and OCT4 (greyscale) in female (LF1 
– XX1) 2iL ESCs at 1.5 days of differentiation in FA. Nuclei are shown in blue (DAPI 
staining). White arrowhead indicates the location of a cell with biallelic Xist upregulation. 
(I) Quantification of Nanog and Oct4 expression profile in the bulk population (left) and in 
cells with biallelic Xist expression (right) as shown in (B). 
(J) Immuno RNA FISH for Xist (red) and cleaved CASPASE-3 (green) in male (E14tg2a) 2iL 
ESCs at 1.5 days of differentiation in FA. Nuclei are shown in blue (DAPI staining). White 
arrowhead indicates the location of an Xist RNA cloud. The percentage of cleaved 
CASPASE-3-positive cells is indicated. None of the cells analyzed were positive for both Xist 
and cleaved CASPASE-3.  
 
The scale bar represents 5 μm.  
